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A quantitative imaging biomarker is a quantitatively measured characteristic derived 
from medical images, which serves as cost-effective and noninvasive tools for patient health 
assessment, including diagnosis and periodic screening of disease, therapy planning as well as 
longitudinal monitoring of treatment response.  
 This dissertation presents an automated framework for quantitative image biomarker 
measurement and evaluation from the low-dose chest CT (LDCT) scans that are acquired 
during the annual lung cancer screening. Four categories of quantitative image biomarkers are 
investigated, including breast density and gynecomastia quantification, bone mineral density 
(BMD), airway dimensions and pulmonary nodule classification. An anatomy directed 
approach is applied to the analysis of the breast region and to the biomarker measurements. 
The fully automated breast density assessment and gynecomastia measurements have been 
demonstrated to be consistent with the reading of radiologists. Fully automated BMD 
assessment is achieved by building upon the model-based segmentation and anatomical 
labeling of individual vertebral body. Statistically significant strong correlation with the gold 
standard reference can be obtained at all vertebral levels. A fully automated knowledge-based 
approach is applied to the segmentation and anatomical labeling of each airway bronchus, 
which enables the measurements of precise and reproducible airway dimensions. For the 
classification of pulmonary nodule malignancy, a 3D CNN is trained from scratch and 
  
demonstrates various advantages over both the traditional machine learning approaches using 
hand-crafted 3D image features and the 2D CNN models. Classifier ensembles of the 
combinations of the 3D CNN and traditional machine learning models achieve the best 
performance by taking advantage of the complementary characteristics of the traditional 
models and the CNN models. 
In conclusion, with the recent large-scale implementation of annual lung cancer 
screening in the US using LDCT, great potential emerges for the concurrent extraction of 
quantitative image biomarkers from different regions in the chest, which are covered in 
LDCT. This dissertation has demonstrated the feasibility of fully automated measurement and 
evaluation of a rich set of quantitative image biomarkers, and the opportunity to significantly 
enhance the impact of LDCT by offering a comprehensive health assessment to each 
screening participant with no additional imaging or radiation exposure.    
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CHAPTER 1 
INTRODUCTION 
A quantitative imaging biomarker is a quantitatively measured characteristic derived from 
medical images as an indicator of normal biological processes, pathogenic processes, or 
responses to an exposure or intervention [1, 2]. Similar to biospecimen-derived biomarkers, 
quantitative image based biomarkers can provide information on anatomically and 
physiologically relevant parameters [1], serving as cost-effective and noninvasive tools [3] for 
patient health assessment, including diagnosis and periodic screening of disease, therapy 
planning as well as longitudinal monitoring of treatment response [4]. 
An extensive variety of quantitative biomarkers can be obtained accurately and 
precisely from medical images with appropriate calibration, owing to the remarkable 
advances in medical imaging technology within recent decades [1, 2, 3]. Many imaging 
biomarkers are nowadays used routinely in healthcare including American College of 
Radiology Breast Imaging Reporting and Data System (ACR BIRADS) mammographic 
breast morphology that is used in breast cancer diagnosis; and bone mineral density T-score 
measured from dual energy X-ray absorptiometry (DXA) scans, which guides the 
osteoporosis diagnosis and the prescription of bisphosphonates to patients with breast cancer 
and bone loss induced by therapy [3].  
 With the rapidly increasing use of medical imaging in current clinical practice, 
especially imaging obtained periodically in the context of annual screening (such as screening 
for breast cancer, lung cancer, cervical cancer and colorectal cancer), a great deal of 
information needs to be interpreted comprehensively by radiologists or other medical 
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professionals within a short period of time. Fully automated extraction and evaluation of 
image biomarkers offer great opportunities to significantly enhance the impact of medical 
imaging [4] by eliminating unnecessary human intervention from the workflow and providing 
precise and reproducible quantitative information that assists the doctors in the further 
interpretation of medical images.  
  This dissertation presents a fully automated framework for quantitative image 
biomarker measurement and evaluation from the low-dose chest CT scans that are acquired 
during the annual lung cancer screening. Four categories of quantitative image biomarkers are 
investigated including biomarkers from the breasts, biomarkers from the bones, biomarkers 
from the airway and biomarkers from the lungs, as illustrated in Figure 1.1.   
 
Figure 1.1. Four categories of quantitative image biomarkers are investigated including (a) 
biomarkers from the breasts, (b) biomarkers form the bones, (c) biomarkers from the airway 
and (d) biomarkers from the lungs. 
 
1.1 Annual lung cancer screening and low-dose chest CT 
Lung cancer is the leading cause of cancer death among both men and women, with 
more people die of lung cancer than of colon, breast, and prostate cancers combined [5]. It is 
estimated that each year in the US, there are 234,030 new cases of lung cancer and 54,050 
lung cancer-associated deaths [5]. Since the symptoms of lung cancer typically do not appear 
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until the disease is already at an advanced stage, the diagnosis of lung cancer is usually 
delayed, and therefore more than 50% people die within one year of being diagnosed [6]. 
The survival for lung cancer is strongly related to the stage at which it is first 
diagnosed. It is demonstrated that the current 5-year lung-cancer–specific survival rate is 
17.7%, while the 10-year lung-cancer–specific survival rate is 80% for people that are 
diagnosed with lung cancer during the annual screening [7], which are usually in curable early 
stage.  
Annual lung cancer screening with low-dose chest CT (LDCT) has been used for early 
detection of lung cancer and has been demonstrated to reduce mortality from lung cancer [8] 
and has been covered by medical insurances since 2015 [9]. It is estimated that 8.6 million 
Americans meet the annual lung cancer screening criteria (current and former smokers who 
were aged 55 years to 74 years) and the use of LDCT is increasing rapidly [10]. As the LDCT 
in general covers the regions of lungs, airway, breasts, mediastinum and several bone 
structures (including clavicles, sternum, ribs and vertebrae), and the lung cancer screening 
population are also at high risk of having a variety of other diseases (such as breast cancer, 
osteoporosis and chronic obstructive pulmonary disease), LDCTs acquired from annual lung 
cancer screening potentially serve as a rich and valuable source for the automated 
measurement and analysis of an extensive variety of quantitative image biomarkers, as 
illustrated in Figure 1.1. 
Lung cancer screening with LDCT is generally accomplished at an overall average 
effective dose below 1.0 mSv for an average-size participant as compared with an average 
effective dose of 7 mSv for a typical standard-dose chest CT examination used in the daily 
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clinical practice [11]. The image noise and absorbed dose are intrinsically linked because they 
both are fundamentally related to the X-ray fluence used during image acquisition [12]. 
Therefore, LDCT scans in general have much higher level of image noise as compared with 
standard dose CT, which makes fully automated analysis of LDCT scans more challenging. 
Therefore, the computer algorithms designed for the standard-dose CT usually do not 
generalize well to LDCT scans.   
 
Figure 1.2 (a-d) Four cases in 3D coronal view in the order of increasing breast density where 
the segmented breast (light green), fibroglandular tissue (dark green) and sternum (grey) are 
shown.   
 
Figure 1.3 Examples of male breasts of different gynecomastia reference grades. For each 
figure, the reference grade is shown on the top and the automated measurement is shown on the 
bottom. 
 
1.2 Automated measurement of quantitative image biomarkers from low-dose chest CT 
Two quantitative image biomarkers, breast density measurement for women as 
illustrated in Figure 1.2, and gynecomastia quantification for men as illustrated in Figure 1.3, 
were investigated from the breast region. Breast density is an independent risk factor for 
breast cancer, which is the most common cancer (excluding skin cancers) diagnosed among 
US women and also the second leading cause of cancer death among US women [13]. Dense 
breasts have up to 6 times greater risk of breast cancer than the less dense breasts, hence 
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leading to legislation mandating that women be informed of their breast density on 
mammogram reports [14]. Breast density is usually assessed using Breast Imaging Reporting 
and Data System (BI-RADS) from mammography, which is currently most commonly used 
modality for breast imaging. The purpose of this study is to take full advantage of LDCT 
scans acquired in the annual lung cancer screening by providing critical measurements about 
breast heath without additional radiation exposure, rather than to use LDCT to replace 
mammography. 
 The second investigated quantitative image biomarker from the breast region is the 
quantification of gynecomastia, which is characterized by the benign enlargement of male 
breasts due to the growth of glandular tissue. It is a common and sometimes distressing 
condition found during physical exam in over half of normal adult men over the age of 44 [15, 
16]. Although the majority of gynecomastia is physiologic (i.e. associated with puberty or aging) 
or idiopathic (i.e., cause is unknown) [15], its occurrence may also associate with an extensive 
variety of underlying systemic disease or drug toxicity [15, 17]. Reliable gynecomastia 
quantification can assist the early detection as well as the treatment of both gynecomastia and 
the underlying medical problems, if any, that cause gynecomastia. 
The assessment of bone mineral density (BMD) plays an essential role in the diagnosis and 
follow-up therapy monitoring of osteoporosis, which is the most common metabolic bone 
disease and is estimated to affect 12.3 million US population aged 50 years or older in 2020 
[18]. Osteoporosis is characterized by low bone density and micro-architectural deterioration 
of bone tissue [19], with related complications, such as osteoporotic fractures, becoming a 
significant cause of increased morbidity and mortality [20], and thereby creating tremendous 
social and economic burdens. This study investigated the BMD measurements and 
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demonstrates the potential of opportunistic osteoporosis screening with concurrent lung cancer 
screening using LDCT. 
 
Figure 1.5 Illustration of airway dimension derived quantitative image biomarkers, including 
lumen diameter and wall thickness. 
 
 Airway dimension derived quantitative image biomarkers, including lumen diameter 
and wall thickness as illustrated in Figure 1.5, have been demonstrated repeatedly to correlate 
well with the severity of airflow obstruction and peripheral airway inflammation in patients 
with chronic obstructive pulmonary disease (COPD), which is a heterogeneous disease 
associated with varying degrees of emphysema and small airways disease [21] and is expected 
to be the 3rd leading cause of death by 2020 [22]. As a consequence, the precise and 
reproducible measurements of airway dimension derived biomarkers may facilitate more 
accurate COPD diagnosis, treatment planning, as well as the evaluation of therapy response 
[21]. 
 Pulmonary nodules are approximately spherical regions (with diameter ⩽ 30 mm) of 
the lungs, which usually appear on CT images as solid tissue having a much higher image 
intensity than the surrounding lung parenchyma [23], as illustrated in Figure 1.6. Sub-solid 
nodules, also known as ground-glass opacities, which grows along the air-containing 
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structures of the lung and has a nonsolid appearance on CT images [23], are much less 
frequent thus are not considered in this study. The detection and malignancy classification of 
the pulmonary nodules are essential during the annual lung cancer screening, as the nodules 
can be benign (noncancerous) that often requires no treatment, or malignant (cancerous) that 
requires medical treatment as soon as possible. The analysis of pulmonary nodule biomarker 
in this study focuses on the prediction of the malignancy status from the initial CT scan 
finding to improve the costly follow-up procedures. 
 
Figure 1.6 Examples of (a) malignant nodule and (b) benign nodule in axial view from LDCT 
scans.   
 
1.3 Overview 
A fully automated framework is presented in this dissertation for the measurement and 
evaluation of quantitative image biomarkers from LDCT scans acquired during the annual 
lung cancer screening. Quantitative image biomarkers from the following four categories of 
were investigated: 
(i). Breast region analysis and quantitative image biomarker measurement in Chapter 2. In 
order the determine the region of interest for the subsequent biomarker measurements, fully 
automated anatomy directed algorithm is first developed for the segmentation of the whole 
breast region and the fibroglandular tissue. Then a machine learning based approach is used to 
for the localization of nipples. Finally, the two quantitative image biomarkers, including 
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breast density for women and gynecomastia quantification for men, are measured and 
validated by comparing to the reference established by the radiologists.    
(ii). Bone structure analysis and quantitative image biomarker measurement in Chapter 3. 
Individual bone structures, including clavicles, sternum, ribs and vertebrae, are first 
segmented sequentially and anatomically labeled by a fully automated model-based 
algorithm. Then building upon each of the segmented and labeled vertebra, the BMD is 
measured and validated by using the BMD measured form the DXA scans the reference.   
(iii). Airway anatomical labeling and quantitative image biomarker measurement in Chapter 
4. Each individual airway bronchus is first segmented and labeled with its anatomical name 
using a knowledge-based approach. Then two airway dimension derived quantitative image 
biomarkers, the lumen diameter and wall thickness, are measured and validated based on the 
reproducibility of the measurements.  
(iv). Pulmonary nodule malignancy classification in Chapter 5. A 3D convolutional neural 
network (CNN) trained from scratch is employed for the classification of pulmonary nodule 
malignancy. Classifier ensembles of different combinations of the 3D CNN and traditional 
machine learning models based on handcrafted 3D image features are also explored. 
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CHAPTER 2 
FULLY AUTOMATED BREAST ANALYSIS AND QUANTITATIVE BIOMARKER 
MEASUREMENTS 
Fully automated breast health analysis from LDCT scans acquired during the annual 
lung cancer screening is considered in this chapter. For female subjects, breast density is 
quantified and can potentially be used for breast cancer risk estimation. For male subjects, the 
gynecomastia quantification is measured and can potentially be used for the gynecomastia 
diagnosis and treatment planning. The presented framework is the first published work on the 
fully automated breast density measurement and gynecomastia quantification from LDCT, 
demonstrating the feasibility of concurrent breast healthy analysis for both women and men 
and annual lung cancer screening without requiring any additional patient time or radiation 
exposure.  
Breast cancer is the most common cancer (excluding skin cancers) diagnosed among 
US women, with approximately 232,340 new cases [13] accounting for nearly 1 in 3 cancers 
in the US each year. It is also the second leading cause of cancer death among US women 
which results in 39,620 deaths in the US each year [13]. Breast density has been shown to be 
an independent risk factor for breast cancer, hence leading to legislation mandating that 
women be informed of their breast density on mammogram reports in many states [14].  
 Mammography is recommended for breast cancer screening by many organizations 
with most US mammograms being 2D full field digital mammograms (FFDM).  Digital breast 
tomosynthesis and 3D imaging modalities, including CT [24, 25, 26], ultrasound [27] and 
MRI [28] are of increasing interest. 3D modalities are free of the inherent superimposition 
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effects of mammography, which is a 2D projection of 3D breast volumes, thereby being 
helpful especially for women with dense breasts, for which mammographic screening may 
have relatively low sensitivity [24, 25, 29]. Several recent studies [24, 25, 26, 30, 27] have 
demonstrated that breast density readings on 3D modalities are consistent with readings on 2D 
mammogram with comparable inter-observer agreement.   
Breast density is usually assessed using Breast Imaging Reporting and Data System 
(BI-RADS) that classifies breast composition into 4 categories [28]. Percentage quartiles are 
no long employed for the division of the density groups in the latest BI-RADS atlas to better 
reflect the masking effect of dense fibroglandular tissue and estimate the density volume [28]. 
There are currently no published studies to validate a computer aided breast density 
assessment framework for LDCT by comparing with the subjective grading of radiologists 
following the latest BI-RADS guidelines.   
Several recent publications have demonstrated that breast density measured from 
LDCT correlates well with density measurements from mammogram and MRI [24, 25]. 
Consequently, LDCT can potentially serve as a valuable resource providing useful 
information with respect to breast cancer risk evaluation for many women who have 
undergone LDCT but not recent mammograms. 
 Gynecomastia is characterized by benign enlargement of male breasts, as shown in 
Figure 2.1, due to the growth of glandular tissue [31], which is a common and sometimes 
distressing condition found during physical exam in over half of normal adult men over the 
age of 44 [15, 16]. Most cases of gynecomastia are due to an imbalance in estrogen and 
androgen action, with estrogen-induced stimulation predominating [15].  
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Figure 2.1. Normal male breasts in (a) axial view and (b) sagittal view and male breasts with 
gynecomastia in (c) axial view and (d) sagittal view. The subareolar regions are indicated by 
arrows. 
 
 Although the majority of gynecomastia is physiologic (i.e. associated with puberty or 
aging) or idiopathic (i.e., cause is unknown) [15], its occurrence may also associate with an 
extensive variety of underlying systemic disease or drug toxicity [15, 31]. Physiologic 
gynecomastia is often an incidental finding and may be painful or cosmetically disabling in 
some men, who may hence benefit from treatment [31]. Drug-induced gynecomastia may be 
treated with discontinuation of an offending drug, if it is identified during the proliferative 
phase (i.e., gynecomastia has been present within a year) [32]. On the other hand, if the 
gynecomastia is of long duration, the breast enlargement is unlikely to regress substantially, 
due to presence of fibrotic tissue [32].  
Gynecomastia must be distinguished from pseudo-gynecomastia [33, 31], which is 
characterized by increased subareolar fat without enlargement of the breast glandular 
component, and requires no further investigation [33]. Although rare in men, gynecomastia 
also needs to be distinguished from breast carcinoma in the differential diagnosis [15]. 
Physical examination without imaging is usually sufficient for the diagnosis of gynecomastia 
[32, 34]. 
The radiographic appearance of gynecomastia on CT scans has been investigated in 
several studies [34, 35, 36], which are all based on subjective reading by radiologists. 
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Although the appearance of gynecomastia has been well described on mammography, 
ultrasound and digital breast tomosynthesis [34, 29], there is no consensus on the standard 
measure for the diagnosis and quantification of gynecomastia [34]. In the study [17] by 
Cooper et al, gynecomastia was quantified using a four-category grading scale based on the 
volume fraction of dense tissue in the subareolar region: gynecomastia was considered mild 
when dense tissue occupied less than 25% of the volume of the subareolar soft tissue; 
moderate when it occupied 25-50% of the subareolar volume; and extensive when it occupied 
more than 50% the subareolar volume. Other studies [34, 36] have employed the maximal 
diameter measured at the axial level of the nipples as the quantity measure of gynecomastia. 
A subareolar glandular tissue diameter of 20 mm and above on CT scans was considered as 
gynecomastia by Klang et al in [36], which is consistent with the diagnosis criteria used in the 
physical examination by Nuttall et al in [16]. 
 As the LDCT in general also covers the regions of breasts and the high prevalence of 
gynecomastia among the lung cancer screening population (current and former smokers who 
were aged 55 years to 74 years), gynecomastia is believed to be a frequent incidental finding 
[34] on LDCT scans acquired during annual lung cancer screening. Therefore, LDCTs can 
potentially serve as a valuable resource for the early detection and longitudinal monitoring of 
gynecomastia, which may aid the treatment of both gynecomastia and the underlying medical 
problems, if any, that cause gynecomastia. 
 The locations of the nipples are important anatomical landmarks as they are the only 
consistent spatial references of human breast [37, 38]. Radiologists often use nipple location 
as the reference point to aid the interpretation of breast imaging [34, 35, 34], including breast 
density assessment and gynecomastia quantification. Computer aided analysis of breast 
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imaging frequently requires automated nipple localization as the first step. The applications 
[37, 39, 40] of fully automated nipple localization include but are not limited to: (1) 
registration of longitudinal breast imaging of the same subject for the monitoring of changes 
occurred in breast; (2) registration of left and right breast imaging for the identification of 
bilateral asymmetry which can be a sign of breast cancer [41]; (3) registration of multi-view 
2D projections or different imaging modalities to aid the diagnosis of breast abnormalities 
[42, 43], such as masses and microcalcifications; (4) construction of an anatomical frame of 
reference facilitating the segmentation of anatomical structures, such as pectoral muscles, fat 
tissue and glandular tissue, and breast density quantification [43, 44]. 
 
Figure 2.2. Five examples of breast region with ground truth annotated (indicated by yellow 
contours) by a radiologist. For each case, both an axial slice and a sagittal slice of the left breast 
are shown. It can be seen that there is a large range of individual variations of breasts. 
 
Figure 2.3. CT (a) axial slice and (b) sagittal slice. Solid arrows mark glandular tissues in the 
breast and dashed arrows mark the muscles in the pectoral regions.  
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A fully automated framework for the breast health analysis from LDCT has been 
developed. The whole breast region is first segmented using an anatomy-orientated approach, 
in which the vertical, anterior and lateral extents of the breast are determined based on the 
spatial constraints defined by other human tissues and organs, and the posterior extent is 
resolved by the propagation of the pectoral muscle fronts as the separation between the breast 
region and the underlying muscles. The subareolar region is then localized using a machine 
learning based nipple detection algorithm. Finally, building upon the region of interest 
defined by the segmented breast and nipple location, two quantitative image biomarker 
measurements, the breast density for women and gynecomastia quantification for men, are 
accomplished. 
Automated breast region analysis on CT images have been presented in several 
previous studies [24, 25, 44, 43, 45, 46, 47], which mainly focused on the breast density 
assessment for female breasts. The segmentation of fibroglandular tissue in the breast region 
usually serves as the first step towards automated breast analysis. Semi-automated template-
based segmentation methods have been presented by Chen et al [24]and by Moon et al [25] 
for LDCT, where manual annotations are needed for the generation of a template slice for 
each scan. Fully automated anatomy-orientated knowledge-based segmentation methods have 
been presented in our own work [45, 46] for LDCT and by Zhou et al [44] for regular dose 
torso CT. A machine-learning based approach has also been employed for the segmentation of 
fibroglandular tissue by Zhou et al [47] for regular dose torso CT. Zhou et al [43] recently 
applied a deep convolutional neural network for the fully automated direct classification of 
female breasts into one of the four density categories without the need of fibroglandular tissue 
segmentation on regular dose torso CT. No previous studies have been found to date on the 
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fully automated breast region analysis of men breasts or gynecomastia quantification on CT 
scans. 
 A number of studies have been conducted on the automated nipple localization [37, 
38, 39, 40, 41, 42, 44, 48], while most of the algorithms were proposed for mammography 
[37, 38, 39, 40, 41, 42] that is a 2D imaging modality. A semi-automated nipple localization 
approach was presented by Gwo et al [48] for breast MRI, using breast imaging coils for 
females in a prone position. For CT, chest images are usually acquired in a supine position. 
Zhou et al [44]proposed a method for nipple localization from standard-dose torso CT as part 
of the breast segmentation algorithm based on the analysis of skin surface curvature and the 
tissue composition near the skin surface. However, the performance of the nipple localization 
algorithm was not reported. 
2.1 Breast segmentation and nipple localization 
There are two main challenges to the automated segmentation of the whole breast in 
LDCT. First, the algorithm must accommodate a significant range of individual variations in 
terms of size, shape, location and tissue compositions of the breasts as illustrated in Figure 
2.2. LDCT scans are usually taken in the supine positions, while other modalities such as 
mammogram, dedicated breast CT, and breast MRI acquire images either in the prone 
position or with breast compression to constrain the location and shape of the breasts. As a 
result, there is a much greater range of variations in terms of shape and location of the breast 
in LDCT images than in images of other modalities. Second, glandular tissues located in the 
posterior breast regions may be difficult to be distinguished from the surrounding muscles in 
the pectoral regions as illustrated by arrows in Figure 2.3, because they have similar CT 
intensity distributions and can be in contact with each other, thereby lacking in well-defined 
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boundaries to exclude the muscles from the breast regions. Moreover, the glandular tissues 
usually have irregular shapes, which complicates the task of separating glandular tissues and 
muscles. 
 
Figure 2.4 Variations of nipples (marked by arrows) across individuals. 
 
Fully automated nipple localization from LDCT is challenging for two primary 
reasons. First, LDCT scans usually exhibit a much higher level of image noise compared to 
standard-dose CT [49], as a much lower overall radiation dose is adopted. Second, there is a 
significant range of variations in the appearance, size, shape, and location of nipples across 
individuals as illustrated in Figure 2.4. While one might expect that the nipple would be 
identified by a “bump” on the surface of the skin pointing out from the body as shown in 
Figure 2.4 (c), a number of alternative presentations are observed in CT images. For example, 
the nipple region may be: smooth as shown in Figure 2.4 (d), inverted as shown in Figure 2.4 
(a), or lacking any glandular tissue and being smooth as shown in Figure 2.4 (b). 
 The main contribution of the presented breast segmentation approach is the novel 
algorithm, muscle front propagation, for the separation of pectoral muscles and fibroglandular 
tissue. It is designed to model and track the muscle front that is more well-defined in terms of 
shape and location compared to the fibroglandular tissues that often have large individual 
variations of in terms of position, volume and shape as indicated in Figure 2.7. It takes 
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advantage of the fact that the muscle front is generally of convex shape and smooth both in 
the vertical direction and the on the axial plane. The main contribution of the nipple 
localization algorithm is the application of machine learning based method and the extraction 
of effective LDCT image features of nipples. Moreover, it is the first published work on the 
fully automated nipple localization from LDCT scans.  
2.1.1 Segmentation of whole breast and fibroglandular tissue 
The whole breast region is modeled in this paper as a two-component region, 
consisting of fat tissue and fibroglandular tissue, which is located outside the thoracic cavity 
and anterior to the chest muscle as indicated in Figure 2.5. The whole breast region is first 
segmented using a novel anatomy-orientated approach based on the propagation of muscle 
fronts to resolve the challenge of separating the fibroglandular tissue from the underlying 
muscle. The fibroglandular tissue and fat tissue are then identified from the segmented whole 
breast and the percentage breast density is calculated based on their volume ratio.  
 
Figure 2.5 (a) Human tissues and organs in the chest region shown in an axial view. (b) 
Whole breast region annotated (in yellow) by a radiologist in an axial CT slice and (c) in a 
sagittal CT slice. 
 
 The segmentation of the whole breast requires the determination of its extents in the 
vertical, anterior, lateral and posterior directions. Several adjacent tissues and organs as 
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illustrated in Figure 2.6 (a), including sternum [50], ribs [51], lungs [23], skin, fat and soft 
tissues [49], are segmented by algorithms developed in our previous studies and employed as 
prior dependence. The presented whole breast segmentation algorithm consists of the 
following three main steps:  
(1). Define the vertical extents of the breast as the range between the superior end of the 
sternum and the inferior end of the lung as shown in Figure 2.6 (b).  
(2). Define the anterior and lateral extents of the breast based on the skin surface as shown in 
Figure 2.6 (c).  
(3). Define the posterior extents of the breast based on the muscle front shown in Figure 2.6 
(c) and obtained by initialization at the superior axial level and then propagation in the 
inferior direction, which is explained in detail.  
 
Figure 2.6 (a) Human tissues and organs used as prior dependence are shown in axial view. 
(b) The vertical extents of the breast are determined based on sternum and lung, shown in 
coronal view. (c) The anterior and lateral extents (in yellow) of the breast are determined 
based on the skin surface. The posterior extents of the breast (in red) are determined based on 
the muscle front.   
 
The third step, muscle front propagation, is a novel algorithm proposed in this paper to 
serve as a solution to the well-known challenge [46, 47] of separating muscle from 
fibroglandular tissue as demonstrated in Figure 2.7. A Cartesian coordinate system, where the 
x, y and z axes are defined along mediolateral, anteroposterior, and craniocaudal directions 
respectively, is established as shown in Figure 2.7 to aid the following description.  
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The muscle front is defined in this paper as the interface of the muscles and other 
adjacent tissues, which are usually fat tissues or fibroglandular tissues. Since at the superior 
level of the breast region (i.e., z = 0, the axial level at superior end of the sternum) there are 
no fibroglandular tissue, the muscle front can be easily initialized based on the boundary 
between fat tissue and non-fat soft tissues as shown in Figure 2.8 (b) (For the remainder of the 
chapter, we will use the term soft tissues to refer to non-fat soft tissues.). The smoothness of 
the muscle front allows the front propagation along the inferior direction through the whole 
vertical range of the breast as shown in Figure 2.8. At the location of where the muscle front 
is not well defined due to the existence of adjacent fibroglandular tissues as in Figure 2.7, the 
front can be resolved according to the adjacent front locations both axially and vertically.  
 
Figure 2.7. The fibroglandular tissue and the underlying muscle can be difficult to separate as 
indicated by arrows in (a) axial view and (b) sagittal view. 
 
Figure 2.8. Muscle front propagation along inferior direction through the whole vertical range 
of the breast shown in (a) sagittal view and (b-d) axial view. 
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The flow chart of the muscle front propagation algorithm is shown in Figure 2.9. The 
remainder of the algorithm description focuses on the right hemithorax using the sternum as 
the medial separation; the algorithm for the left side is similar due to symmetry. 
 
Figure 2.9. Flow chart of the muscle front propagation algorithm. 
 
The muscle front is modeled as a surface f(x, z) that is parametrized by the x and z 
coordinates. It is initialized at the superior level z = 0 of the breast and propagated towards the 
inferior direction as z increases. As shown in Figure 2.10 (a), at each axial level z, the muscle 
front f(:, z) consists of two components: the medial muscle front ( MFm
z  ) and the lateral 
muscle front (MFl
z), where a pivot pz =  (𝑝x
z ,  py
z) is located at the border between them.  
The lateral muscle front MFl
z separates the breast region from the posterior body and 
eliminates the need of front propagation of muscles in the back, such as muscles attached to 
scapula. The lateral muscle front serves the same purpose as the medial muscle front in 
excluding muscles from the breast region and constituting a posterior extent of the breast 
region.   
The medial muscle front MFm
z  is defined as the anterior interface of the muscles 
anterior to MFl
z and outside the chest cavity (CC), where CC is approximated by the 3D 
convex hull of sternum, ribs and lungs as illustrated in Figure 2.10 (b-c). The pivot pz is 
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defined as the most lateral point (with smallest x coordinate for the right size of the body) on 
MFm
z .  
The front candidates (FC) as illustrated in Figure 2.10 are potential locations to which 
the medial muscle front can propagate, and defined as the boundary pixels of the union of soft 
tissues and chest cavity CC. The boundary of the CC is also considered as FC in order to deal 
with the location on the chest wall with no significant soft tissue attached as indicated in 
Figure 2.10 (c). 
 
Figure 2.10. (a) Muscle front f(x,z) shown in an axial slice z. (b-c) The front candidates (FC, 
in blue) and the chest cavity (CC, in magenta) in (b) axial view and in (c) magnified view of 
the circled region in (b). The arrow points at the location where the FC lies on the boundary of 
CC due to the lack of attached soft tissue. 
 
At the superior breast extent z = 0, the lateral muscle front MFl
0 is initialized by 
determining the y level yl
0 that minimizes the following score function (2.1) as shown in 
Figure 2.11, which aims to located a y level with minimal amount of soft tissues S(y) to avoid 
cutting through any fibroglandular tissue. Greater lateral body width W(y) is also encouraged 
based on empirical observations. 
yl
0 =  argmin
yp
0  < 𝑦< ya
0
α S(y)  +  β W(y)                                                 (2.1) 
S(y) = ∑ 1ST (𝑥, y
′)𝑥 < xc0 (𝑦),   | y′−𝑦| < δ𝑠                                              (2.2) 
W(y) = xc
0(y)  -  xl
0 (y)                                                           (2.3) 
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α > 0,  𝛽 < 0                                                               (2.4) 
where α and 𝛽 are weight constants; ya
0 and yp
0 are anterior and posterior search limits at z = 0 
respectively; 1ST (𝑥, y) is the indicator function for soft tissues; δ𝑠 is the constant window 
size for counting soft tissue pixels; xc
0(𝑦) and xl
0 (y) are the most lateral x coordinates of the 
chest cavity and the breast region at z= 0 and y. 
The medial muscle front MFm
0  can be easily identified, since at z = 0 there is no 
fibroglandular tissue and any segmented soft tissues are thus muscle. As indicated in Figure 
2.11, MFm
0   can thereby be determined by searching for the most anterior FC pixels at each x 
coordinate. Note that only regions anterior MFl
0 needs to be considered. The pivot p0 can also 
be easily determined by locating the most lateral point on MFm
0  as shown in Figure 2.11. 
 
Figure 2.11. Initialization of muscle front (in red) at the superior extent (z = 0) of the breast.  
 
As the front propagates in the inferior direction to the axial level z, the lateral muscle 
front MFl
z in general needs to be adjusted from previous locations MFl
z−1.  A similar score 
function (2.5-2.6) as that defined in (2.1-2.4) is used to determine y level yl
z with an additional 
term to penalize unnecessary movement from 𝑦l
z−1 that encourages a smooth breast boundary.   
  yl
z =  argmin
yp
z  < 𝑦< ya
z
α S(y) +  β W(y) +  γ |yl
z −  yl
z−1|                              (2.5) 
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α, 𝛾  > 0,  𝛽 < 0                                                           (2.6) 
The determination of medial muscle front MFm
z  at an inferior axial level can be 
difficult due to the existence of fibroglandular tissues. Fortunately, the smoothness and 
continuity of the muscle surface suggests that MFm
z−1 on the previous axial level can be used 
as a reliable starting point for the search of the new front location MFm
z  and this search can be 
constrained within a limited search window. The algorithm for propagating MFm
z  at each 
location (x, z) is summarized in equation (2.7-2.8) below, where the front on the previous 
axial level f(x, z-1) serves as the starting point, and the determination of f(x, z) is in fact an 
optimization of the y coordinate: 
f(x, z) = argmax
 y < f(x,   z−1)+ δ𝑓,   1FC (x, y′)=1 for ∀ yn <  y′< y 
  y                        (2.7) 
where, 
yn  =  argmin
 |y− f(x,   z−1) |< δ𝑓 ,   1FC (x,   y) =1 
| y −  f(x, z − 1)|                      (2.8) 
1FC (𝑥, y) is the indicator function for front candidates (FC); δ𝑓 is the search window along y 
axis, and yn is the FC that is nearest to the start point f(x, z-1). 
Note that it is possible that at some x coordinate, the muscle front f(x, z) cannot be 
resolved due to the lack of FC in the search window, generally resulting from closely attached 
fibroglandular tissue. These front locations will eventually be determined based on filtering 
among neighboring front locations later. 
 Three types of filtering are applied sequentially to the muscle front to ensure a smooth 
and closed posterior breast boundary: 
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First, the medial muscle front MFm
z  is smoothed based on the propagation speed that is 
measured as the location difference f(x,z) – f(x, z-1) between axial level z and z -1. An outlier 
is identified and marked as unresolved if its speed is significantly different from the average 
speed in the axial neighborhood.  
Second, the whole muscle front MFz is smoothed based on continuity that is measured 
as the location difference f(x, z) – f(x -1, z) in the axial neighborhood on the current axial 
level z. An outlier is identified and marked as unresolved if its location difference is 
significantly different from that in the axial neighborhood.  
Finally, the y coordinates of the unresolved muscle fronts are determined by linear 
interpolation of the nearby resolved front locations.  
2.1.2 Nipple localization 
The breast is modeled by a three-compartment region for the purpose of nipple 
localization, consisting of skin, fat tissue and fibroglandular tissue. Three types of anatomy-
oriented image features (6 feature values in total) including spatial location, depth of density 
and degree of protuberance are extracted for each pixel at the skin surface. Spatial location is 
employed due to the fact that nipple is located inferiorly to the jugular notch at the anterior 
front of the skin surface. Left and right nipples are approximately symmetric to the jugular 
notch. Depth of density is used because of the converging characteristics of breast density 
(non-fat tissue) at the nipple [39]. Degree of protuberance is considered based on the 
observation that a nipple is often characterized by a “bump” pointing out from the body or an 
“indentation” towards the body (for an inverted nipple as in Figure 2.4(a)). 
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Figure 2.12 Flowchart of the nipple localization algorithm. (a-b) Segmented fat (yellow), 
sternum (blue) and skin surface (red). (c) True positive candidate. (d) False positive 
candidate. (e-f) Determined nipple marked by square, with fitting plane shown in red and 
surface normal shown in blue. (a,c,d,e) are shown in axial view and (b,f) are shown in sagittal 
view.  
Skin surface S, fat tissue F and jugular notch (jx, jy, jz) are first obtained using the 
methods presented in our previous work [49, 50]. A 3D Cartesian coordinate system is used in 
the following as illustrated in Figure 2.12(a): x, y, and z axes are oriented in left-right, 
posterior-anterior, and cranial-caudal direction respectively. The left and right nipples are 
separated based on the lateral location to the jugular notch.  
The spatial location features, fx(s), fy(s), and fz(s), for a given skin pixel s = (sx, sy, sz) 
∈ S are defined based on the jugular notch (jx, jy, jz): 
fx(s) = |sx - jx| / dx                                                    (2.9) 
fy(s) = (sy - jy) / dy                                                   (2.10) 
fz(s) = sz - jz                                                           (2.11) 
where dx and dy are the lateral width and anteroposterior width of the body respectively. The 
features defined in (2.9) and (2.10) are normalized by dx and dy to take into account of 
different size of the body. The absolute difference used in (2.9) allows the left and right 
breasts to be considered separately while using the same classifier trained with left and right 
nipples together.  
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 For the feature computation of the depth of density and the degree of protuberance at a 
given skin pixel s, a 3D plane P(s) as defined in (2.12) and illustrated in Figure 2.12 (e-f) is 
first fitted in the sense of least squared error for a set of surface skin pixels N(s) in the 
neighborhood centered at s with radius of dn mm.  
(x - cx, y - cy, z -cz) • (nx, ny, nz) = 0                                  (2.12)  
Where • is the inner product of two vectors; n = (nx, ny, nz) is the surface normal vector as 
illustrated in Figure 2.12(e-f), and it is ensured to point towards the body; (cx, cy, cz) is the 
centroid of the neighborhood set N(s), and it is ensured to be on the fitted plane.  
The depth of density features fd(s) and f∆d(s) are then defined as follows: 
fd(s) = min{distance(s, f),  for f ∈ F, (f - s) • n = |f||n|}                         (2.13) 
f∆d(s) =  fd(s)  - min{fd(t),  for t ∈ N(s)}                                 (2.14) 
where fd(s) is the depth of density (non-fat tissue) along the surface normal direction n under 
skin pixel s; f∆d(s) is the difference between density depth at s and the local minimum depth in 
the neighborhood N(s).  
The degree of protuberance fp(s) is a measure of the amount of deviation of s from the 
fitted plane P(s), which is the distance from s to P(s) as defined in (2.15): 
fp(s) = (cx - sx, cy - sy, cz- sz) • (nx, ny, nz)                               (2.15) 
As the surface normal n = (nx, ny, nz) is ensured to point towards the body, fp(s) > 0 at the 
“bump” pointing out from the body; while fp(s) < 0 at the “dent” pointing inwards to the body. 
 The set of features described above are computed for each skin surface pixel s that is 
inferior to the jugular notch and located in the anterior 2/3 of the skin surface. A skin surface 
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pixel s is considered to be a nipple candidate if either of the following two criteria is satisfied 
as illustrated in Figure 2.12 (b-c): 
(1). |fp(s)| is a local maximum N(s) and |fp(s)| > tp. 
(2). fd(s) is a local maximum in N(s), fd(s) > td and f∆d(s) > t∆d.     
A machine learning classifier is employed to discriminate the true nipples from the 
false positive candidates, i.e., candidates that are proposed but are not nipples as shown in 
Figure 2.12(c). Seven commonly used classifiers, including logistical regression, SVM linear, 
SVM polynomial, SVM RBF, decision tree, random forest, and AdaBoosted tree, were 
explored. All features described above and the truth label (1 for candidate within 13 mm to 
the true nipple location; 0 for other candidates) for each proposed candidate in the training set 
are used to train the classifiers. The hyper-parameters of the classifiers are tuned based on the 
performance of the validation set.  
 During the testing phase, for each of the trained classifier and each breast in the testing 
set, all proposed candidates are first tested with the classifier, and a prediction score is 
obtained, where a higher score indicates a greater probability of being a nipple. The candidate 
with the highest prediction score for each side of the body, is then considered as the nipple 
location as illustrated in Figure 2.12 (d-e).  
2.2 Quantitative imaging biomarkers from the breast 
Two imaging biomarkers, breast density for female subjects and gynecomastia 
quantification for male subjects, are measured within the regions of interest, which are 
defined based on the segmented whole breast region and localized nipples.  
2.2.1 Female breast density quantification 
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The region of interest used for the breast density measurement is denoted as local 
whole breast region and defined as the segmented breast region within d mm from the 
fibroglandular tissue (i.e., segmented soft tissues contained in the segmented breasts). The 
volume ratio of the fibroglandular tissue to the local whole breast region is then calculated 
and reported as the CT breast density. The left and right breasts are considered separately, and 
the higher density is used as the reported breast density as done in clinical practice [28].      
 
Figure 2.13.  Flowchart of the gynecomastia detection framework. (a-b) Localized nipples 
marked by squares. (c) Segmentation of breast (light green) and fibroglandular tissue (solid 
green). (d) Identified subareolar region (light green) and gynecomastia (solid green). The 
segmented sternum (grey) is also shown in (c-d) for reference.  
 
2.2.2 Male gynecomastia detection 
The fully automated gynecomastia detection framework from LDCT consists of three 
main stages as illustrated in Figure 2.13. First, the nipple is localized for each side of the 
body. Second, the whole breast and the fibroglandular tissue is segmented based on the 
muscle front propagation algorithm presented in section 2.1. Third, the subareolar region is 
then defined as the segmented breast region within ds mm to the localized nipple obtained 
using algorithm presented in section 2.2. The volume of segmented fibroglandular tissue 
within the subareolar region is measured for the gynecomastia assessment. 
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2.3 Experiments 
The breast segmentation framework was validated using 1270 non-contrast LDCT 
images from ELCAP, LIDC and FAMRI datasets, most of which were performed for lung 
cancer screening. Visual inspection was used to evaluate the performance of the whole breast 
segmentation in both 2D axial view and coronal 3D view as shown in Figure 2.14. The results 
were considered unacceptable if segmentation errors, such as inclusion of muscle into the 
breast region or under-segmentation of fibroglandular tissue, may influence further breast 
analysis including density assessment and breast mass detection.  
 
Figure 2.14. An example of visual inspection used during validation of breast segmentation. 
(a-b) 9 axial views uniformly sampled along the vertical range where segmented 
fibroglandular tissue (green), breast (yellow) and sternum (red) are shown. (c) 3D coronal 
view where the segmented fibroglandular tissue (dark green), breast (light green) and sternum 
(grey) is shown. 
 
The nipple localization algorithm was validated using the training set and validation 
set consisting of 440 nipples (from 220 non-contrast LDCT scans) selected from ELCAP and 
LIDC datasets, where the gender information is unavailable. 85% (374) nipples were used for 
training and 15% (66) nipples were used for validation. The testing set consists of 838 nipples 
(from 419 non-contrast LDCT scans) selected from FAMRI dataset, consisting of 448 male 
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nipples and 390 female nipples. As these LDCT scans were acquired during lung cancer 
screening focusing on lungs, the breast region may be truncated in some scans. The dataset 
used here are constructed by including all scans having both nipples within the scan field of 
view from the three datasets. The ground truth nipple location was annotated manually for 
each breast. The outcome of the nipple localization algorithm is considered correct if the 
distance between the predicted nipple and the ground truth is within 2 cm. 2 cm is employed 
because it is approximately the maximal diameter of the nipples in the training set.   
The automated breast density assessment was validated using a subset of 100 scans of 
female subjects randomly selected from the validation set. The density ground truth was 
established by an experienced radiologist (L.M., 28 years of mammography experience and 
23 years of CT experience) by reviewing the CT scans and classifying each case into one of 
the 4 categories following the latest BI-RADS guidelines [28]: grade ‘a’ for breasts that are 
almost entirely fatty; grade ‘b’ for breasts with scattered areas of fibroglandular density; grade 
‘c’ for breasts that are heterogeneously dense; and grade ‘d’ for breasts that are extremely 
dense. Cases located at the borderline between two categories were also marked by the 
radiologist. The distribution of reference density assigned by the radiologist is shown in 
Figure 2.15, which generally agrees with the common distribution across density categories as 
reported in the BI-RADS guidelines [28]. 
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Figure 2.15. The distribution of the BI-RADS breast density assigned by the radiologist for the 
100 scans used for the validation of the automated breast density assessment.     
 
 The gynecomastia quantification framework was validated using 448 breasts from 
LDCT scans of 224 adult men, which is the male subset of the testing set used in the 
evaluation of nipple localization. As there is still no consensus on the standard measure for 
the diagnose and quantification of gynecomastia [34], the gynecomastia reference standard 
used in this paper was established by an experienced radiologist who specializes in breast 
imaging using a 5-category grading scheme, where left and right breasts are considered 
separately. Grade 0, 0.8, 1, 2, 3 are assigned respectively to breasts with increasing amount of 
fibroglandular tissue in the subareolar region following the below guideline: 
Grade 0: for breasts that are almost entirely fatty in the subareolar region. 
Grade 0.8:  for breasts with minimal fibroglandular density in the subareolar region. 
Grade 1: for breasts with mild fibroglandular density (axial diameter < 2 cm) in the 
subareolar region. 
Grade 2: for breasts with moderate fibroglandular density (axial diameter between 2 
cm and 4 cm) in the subareolar region. 
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Grade 3: for breasts with marked fibroglandular density (axial diameter > 4 cm) in the 
subareolar region. 
Examples of breasts of different reference grades are shown in Figure 2.16. Grade 0 – 3 
account for 33.0%, 32.8%, 21.4%, 9% and 3.8% of the whole dataset respectively.  
 
Figure 2.16 Examples of male breasts of different gynecomastia reference grades. For each 
figure, the reference grade is shown on the top and the automated measurement is shown on the 
bottom. 
 
 The Spearman’s rank correlation was used to measure the concordance between the 
continuous gynecomastia measurements obtained by the automated framework and the 
categorical reference grades. To evaluate the performance for gynecomastia detection, breasts 
with reference grades of 0 and 0.8 were considered as negative and breasts with reference 
grades of 1 and above were considered as positive. The Receiver Operating Characteristic 
(ROC) curve and its area under the curve (AUC) were used to evaluate the diagnostic 
performance of the automated gynecomastia measurements. 
2.4 Results 
Satisfactory breast segmentation was achieved in 96.1% of the total 1270 LDCT 
scans, and only 0.79% of the scans had unacceptable segmentation due to the breast 
segmentation algorithm. 80% of the unacceptable segmentation was caused by the failure of 
prior dependence algorithms. Four examples of segmentation arranged in the order of 
increasing breast density are shown in Figure 2.17.  
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Figure 2.17. (a-d) Four cases in 3D coronal view in the order of increasing breast density 
where the segmented breast (light green), fibroglandular tissue (dark green) and sternum 
(grey) are shown.   
 
 All true nipples have been identified during the candidate proposal phase with on 
average 11.8 (median of 9) false positive candidates per breast. False positive nipple 
candidates as shown in Figure 2.12 (d) usually occur at skin folds, moles or uneven skin 
depth. The performance of using different machine learning classifiers are very similar. The 
best performance is obtained by using an SVM polynomial with degree of 2: 99.2% (831 out 
of 838) nipples in the testing set were correctly localized. 7 nipples consisting of 1 male 
nipple and 6 female nipples, were incorrectly localized. The incorrectly localized male nipple 
is shown in Figure 2.4 (b), where either the density depth beneath the skin or the degree of 
protuberance on the skin surface is insufficient. The 7 incorrectly localized female nipples are 
all from remarkably dense breasts, where the density depth at the nipple is not necessarily 
located at the local maximum as illustrated in Figure 2.4 (d).  
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Figure 2.18. The box-and-whisker plot of the continuous density measurement obtained by 
the automated framework with respect to the subjective BIRADS density categories as the 
reference. 
 
Table 2.1. The confusion matrix of the automated categorical density assessment and the 
reference BI-RADS density.     
 Automated  
1 2 3 4 total 
Reference a 12 0 0 0 12 
b 4 36 4 0 44 
c 0 1 33 0 34 
d 0 0 2 8 10 
 
 The comparison of the continuous breast density measurement and reference 
subjective grading is shown in Figure 2.18, where the Spearman’s rank correlation was 0.91 
(p-value < 0.001). After converting the automated measurements to categorical values using 
percentage cutoffs, the comparison is summarized by the confusion matrix shown in Table 
2.1. Only 9 of the 100 scans were classified differently by the automated framework and the 
radiologist (by only 1 category difference), leading to the same density assessment in 91% 
cases. Since 6 out of these 9 scans were marked as at borderline by the radiologist, the breast 
density measurement of 97% scans can be considered consistent. 
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Figure 2.19. (a) Box-and-whisker plot of the automated gynecomastia measurements w.r.t. 
the reference grades. (b) ROC curves of using automated measurements for gynecomastia 
diagnosis. 
 
For the evaluation of the nipple localization based gynecomastia detection, the 
Spearman correlation r = 0.76 (p-value < 0.001) is obtained between the automated 
gynecomastia measurements and the reference grades. The box-and-whisker plot of 
gynecomastia measurements is shown in Figure 2.19 (a). Examples of automated 
measurements for breasts of different reference grades are shown in Figure 2.16. The 
diagnostic performance of the automated gynecomastia measurements is given by the ROC 
curve shown in Figure 2.19 (b), in which the AUC = 0.91. Compared to the results presented 
in our previous study [52], the benefits of including the nipple location in the gynecomastia 
detection framework are given by the statistically significant improvement in Spearman 
correlation (0.70 vs 0.76, p-value < 0.001) and a positive trend in the AUC (0.86 vs 0.91, p-
value = 0.065). 
2.5 Discussion 
 The separation of pectoral muscles from the fibroglandular tissue is regarded as one 
of the greatest challenges for breast segmentation [46, 47] due to the lack of a well-define 
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boundary and the large individual variations of the fibroglandular tissues in terms of position, 
volume and shape as indicated in Figure 2.7. The solution presented in this study, muscle 
front propagation, focuses on the anterior front of the pectoral muscle that is much better-
defined with a regular shape and smooth boundary.  
 
Figure 2.20. Example 1 of radiologist/computer discordance. (a,c) Two axial slices of the 
original CT scan. (b,d) The corresponding segmentation where the fibroglandular tissue (green), 
breast (yellow) and sternum (red) are shown. The arrows indicate the locations with over-
segmentation of fibroglandular tissue.  
 
Figure 2.21. Example 2 of radiologist/computer discordance. (a,c) Two axial slices of the 
original CT scan. (b,d) The corresponding segmentation where the fibroglandular tissue (green), 
breast (yellow) and sternum (red) are shown. The arrows indicate the locations with over-
segmentation of fibroglandular tissue due to high level of noise.  
 
Figure 2.22. Example 3 of radiologist/computer discordance. (a,c) Two axial slices of the 
original CT scan. (b,d) The corresponding segmentation where the fibroglandular tissue (green), 
breast (yellow) and sternum (red) are shown. The arrows indicate the locations with under-
segmentation of fibroglandular tissue.  
 
The muscle front is modeled as a surface f (x,z) that is parameterized with image 
coordinates, instead of arc length as used by active contour models. It avoids the periodic re-
parameterization and facilitates the front evolution, as for each x coordinate only variation in 
the y direction is considered, with the guarantee of a closed breast boundary consisting of the 
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anterior skin and the posterior muscle front on each axial level. This simplified contour model 
may not work well in a general contour propagating scenario, whereas it is sufficient for the 
muscle front due to its approximately convex shape and smoothness. 
There are only 3 cases (out of 100) for which the density assessment by the automated 
framework is inconsistent with that of the radiologist, demonstrating the encouraging 
performance of the presented automated approaches.  As shown in Figures 2.20-2.22, they all 
contain different types of segmentation issues, such as inclusion of muscles into the breast 
region as shown in Figure 2.20, under-segmentation of fibroglandular tissue as shown in 
Figure 2.21, and miss-classification of fibroglandular tissue due to high level of image noise 
as shown in Figure 2.22. For the future work, we plan to gather more discordant cases or 
cases with apparent problems and we plan to develop a more advanced density measurement 
approach, instead of the simple percentage volume ratio used here, so that the algorithm is 
more robust with respect to subtle segmentation issues.  
The presented study is one of the first few studies [44, 48] on automated nipple 
localization from 3D imaging modality, which can potentially aid the aid a number of 
automated breast analysis tasks, such as breast density assessment [43], breast mass detection 
[41], breast cancer diagnosis [41, 42] and gynecomastia detection. The nipple localization 
algorithm was developed and evaluated for both female and male subjects, whereas the prior 
work on the automated breast analysis mainly focus on female subjects. 99.2% (831 out of 
838) nipples in the testing set were correctly localized, which demonstrates the strength of the 
proposed anatomy-orientated image features and the efficacy of the machine learning 
classifiers on the task of fully automated nipple localization from LDCT.   
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Except our own prior work [52], only a small number of studies [34, 35] have 
investigated gynecomastia on CT scans, and these are all based on subjective reading by 
radiologists. Sonnenblick et al have demonstrated the feasibility of using chest CT for the 
confirmation of diagnosis for men with clinical symptoms of gynecomastia [34]. The results 
presented in this study further shows the feasibility of gynecomastia detection from LDCT 
using fully automated system, which may aid the early detection as well as the treatment of 
both gynecomastia and the underlying medical problems, if any, that cause gynecomastia. 
2.6 Conclusion 
A fully automated framework has been presented for breast heathy analysis from the 
LDCT acquired during annual lung cancer screening. The whole breast region is first 
segmented using an anatomy-orientated approach. The subareolar region is then localized 
using a machine learning based nipple detection algorithm. Finally, building upon the region 
of interest defined by the segmented breast and nipple location, two quantitative image 
biomarker measurements, the breast density for women and gynecomastia quantification for 
men, are accomplished. The automated breast segmentation has been visually validated with 
1270 LDCT scans and achieved satisfactory outcomes in 96.1% scans. The automated density 
assessment was consistent with subjective reading of an experienced radiologist in 97 of 100 
scans. Breast density assessment from LDCT can potentially serve as a valuable resource 
providing useful information with respect to breast cancer risk evaluation for many women 
who have undergone LDCT but not recent mammograms. The automated gynecomastia 
quantification was validation using 454 breast regions from non-contrast LDCT scans of 227 
adult men. The gynecomastia reference standard was established by an experienced 
radiologist by reviewing the CT scans and classifying each breast into one of the five 
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categorical scores. The automated gynecomastia measurements have been demonstrated to 
achieve promising performance for the gynecomastia diagnosis with the AUC of 0.91 for the 
ROC curve and have statistically significant Spearman correlation r=0.76 (p < 0.001) with the 
reference categorical grades. The encouraging results demonstrate the feasibility of fully 
automated gynecomastia quantification from LDCT, which may aid the early detection as 
well as the treatment of both gynecomastia and the underlying medical problems, if any, that 
cause gynecomastia. 
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CHAPTER 3 
FULLY AUTOMATED BONE ANALYSIS AND QUANTITATIVE BIOMARKER 
MEASUREMENTS 
Skeletal structures, including clavicles, sternum, ribs and vertebrae that are covered by low-
dose chest CT (LDCT), establish a reliable frame of reference to other non-rigid human 
organs in the chest region. Therefore, the segmentation and labeling of individual bones 
usually serve as a necessary prior step to the automated analysis of other organs, such as 
breasts [46, 45, 53], heart [54, 55, 56, 57] and lungs [58, 59]. In addition, quantitative image 
biomarkers, such as bone mineral density [60], vertebra compression fracture [61] and spinal 
curvature [62], measured from the spine provide valuable information for the diagnosis and 
treatment of a variety of skeletal diseases, such as osteoporosis and bone deformity.  
 The main contribution of the study is to present a fully automated framework for the 
bone mineral density quantification from LDCT scans, which has never been addressed in any 
previous publications, and provides the opportunity for the concurrent osteoporosis screening 
with annual lung cancer screening. The framework consists of two main stages: First, 
individual bone structures, including clavicles, sternum, ribs and vertebrae, are segmented and 
labeled with anatomical names, as presented in section 3.1. Second, individual vertebral 
bodies are individually segmented and the bone mineral density (BMD) is quantified as 
presented in section 3.2.        
3.1 Individual bone structure segmentation and labeling from low-dose chest CT 
The segmentation and labeling of the individual bone structures serve as the first step 
to the fully automated measurement of skeletal characteristics and the detection of 
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abnormalities. For example, spinal curvature has been used for the diagnosis of skeletal 
deformities [62]; bone mineral density measurement has been used for the diagnosis of 
osteoporosis [60]; quantitative geometry and intensity analysis of the individual vertebra has 
been used for the detection of vertebral fractures [61]. Moreover, the landmarks identified on 
the respective bone structures can potentially provide relatively robust and reliable location 
reference to other non-rigid human organs, such as breast [46, 45, 53], heart [56, 55, 54, 57] 
and lung [58, 59] that may have variable position and shape across individuals and during 
breathing, thereby facilitating the corresponding segmentation and analysis. Furthermore, 
these skeletal landmarks can also be employed to establish a standard frame of reference [58] 
in the chest region that allows image registration of cross-sectional CT scans as well as 
longitudinal scans of the same subject through non-linear transformations. 
 A fully automated framework for the segmentation and labeling of individual bone 
structures from LDCT is investigated in this study. These skeletal structures include both 
clavicles, sternum, all ribs and thoracic vertebrae. In addition, 28 robust skeletal landmarks 
from these structures are also identified. The proposed anatomy-directed system consists of 
four main stages as outlined in the flowchart in Figure 3.1. The stages are ordered so that the 
subsequent stages are built upon the results of previous stages to optimize the overall success 
rate. 
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Figure 3.1. The flowchart of the bone segmentation and labeling framework.  (a) The coronal 
visualization of the input scan generated by image thresholding and noise reduction filtering. 
(b-e) The segmentation and labeling of clavicles, sternum, ribs, and vertebrae. Note that left 
and right side are assigned with different labels but are shown in the same color here. The 
landmarks output in each stage are shown as dots.  
 
This study addresses the bone segmentation and labeling in the context of the high 
image noise of chest LDCT. There have been a number of previous studies that focused on the 
segmentation of separate bone categories including: sternum by Liu et al [50], ribs by Lee et 
al [51], and vertebra by Reeves et al [63]. A study on the overall bone structure segmentation 
and recognition system from torso CT scans using intensity-based and anatomy-directed 
approaches has been presented by Zhou et al [64]. The segmented vertebrae, ribs, sternum and 
bones of upper limbs and lower limbs were evaluated with 48 torso scans and achieved above 
90% success rate. Moreover, a model-based approach has been presented by Klinder et al [65] 
to segment and label individual ribs and vertebrae from chest CT scans. The mean rib cage 
model was applied to 18 CT scans (no CT protocol specified), resulting in successful 
segmentation and labeling in 16 scans. Additionally, significant effort has been devoted to the 
automated analysis of ribs [66] and vertebras [60, 61], however, these algorithms may not in 
general translate well to the recent chest LDCT protocols due to the higher levels of image 
noise and artifacts [49]. 
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3.1.1 Method 
The proposed framework consists of four main stages as outlined in Figure 3.1, where 
stage 2 and 3 are updates of previous published algorithms [50, 51]: 
1) The clavicles are segmented by fitting a piecewise cylindrical envelope for the 
posterior part and by region growing for the anterior part. Two clavicles are then 
labeled as the right and left clavicles. 
2) The sternum is segmented based on image intensity analysis under the spatial 
constraints provided by the segmented clavicles.  
3) The individual ribs are segmented with anatomical names by 3D region growing 
within the volume of interest defined with reference to the spinal canal centerline and 
lungs. 12 right rib labels and 12 left rib labels are assigned to 24 ribs based on the 
spatial relationship.   
4) The individual vertebrae are segmented based on image intensity analysis in the 
spatial region constrained by the previously segmented bone structures. Individual 
vertebra is labeled with its anatomical name, such as C7 (7th cervical vertebra), 
T1(first thoracic vertebra), and L1 (first lumbar vertebra), by matching the vertebra 
and the labeled left and right ribs. Rib labels may also be corrected if unmatched left 
and right ribs connected to the same vertebra are detected.   
3.1.1.1 Clavicle segmentation and labeling 
The clavicle is a long bone that runs transversely and articulates medially with the 
manubrium of the sternum and laterally with the acromion of the scapula as illustrated in 
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Figure 3.1 (a). Located directly above the rib cage, it is usually the most superior bone 
structure visible in the thoracic CT scan, thereby serving as an important anatomical reference 
for the automated analysis and quantitative measurement of the chest CT. Accurate and robust 
segmentation of the clavicles provide a reliable starting point for the rib and sternum 
segmentation and labeling.  
The clavicle is the most superior bone structure that is located at the same level with 
the airway along the anteroposterior axis. Therefore, a seed point on each of side of the 
clavicles can first be identified with respect to the segmented airway and serve as the starting 
point for the later segmentation. The posterior clavicles, defined as the clavicles posterior to 
the seeds, have well-defined shape that can be modeled by a piecewise cylindrical envelope; 
whereas the anterior clavicles, defined as the clavicles anterior to the seeds, are more difficult 
to model using a regular shape constraint. As a result, posterior clavicles and anterior 
clavicles are segmented using different approaches. The clavicle segmentation algorithm is 
summarized in the following three steps. 
Step 1: Seed point identification  
A seed point of the left/right clavicle as shown in Figure 3.2 (a) is detected at the 
center of mass of the most superior high-intensity pixels (intensity threshold Tc) located to the 
left/right of the airway. The airway is segmented using a previously published algorithm [67] 
and also shown in Figure 3.2 (a). 
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Figure 3.2. (a) The left/right seed (marked by the red cross) is located to the left/right of the 
airway (in green). (b) The piecewise cylindrical envelope is used to model the clavicle 
posterior to the seed. (c) Each cylinder segment consists of a central cylinder (yellow) and the 
outer shell (cyan).  
 
Step 2: Segmentation of clavicles posterior to the seeds 
The clavicle posterior to the seed point is modeled with a piecewise cylindrical 
envelope consisting of a series of cylinder segments with overlapping centerlines and variable 
radii and directions as indicated in Figure 3.2 (b). Each cylinder segment is composed of a 
central cylinder modeling the trabecular bone tissues of low image intensity (intensity 
threshold Tc) and an outer shell modeling the cortical bone of high image intensity as shown 
in Figure 3.2 (c). It is defined by 5 parameters as indicated in Figure 3.2 (c), including 2 pre-
established parameters, the height h of the segment and the width w of the outer shell, and 3 
parameters, the radius r of the central cylinder, and two angles 𝛼 and 𝛽 that determine the 
direction of the centerline, which are optimized after the fitting procedure. 
Starting from the seed, a series of cylinders with overlapping centerlines are fitted into 
the scan iteratively by determining the optimal radius and direction of each cylinder segment 
that corresponds to the greatest matching score as defined in equation (3.1), which is the sum 
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of the percentage of low intensity pixels contained in the central cylinder and the percentage 
of high intensity pixels contained in the outer shell. 
r, 𝛼, 𝛽  =  argmax
𝑟,   𝛼,   𝛽
 ∑
1central (Im(x,y,z)<Tc)  + 1shell (Im(x,y,z)>Tc)  
𝜋(𝑟+𝑤)2 ℎ  
(𝑥,𝑦,𝑧) 𝑤𝑖𝑡ℎ𝑖𝑛 
𝑡ℎ𝑒 𝑐𝑦𝑙𝑖𝑛𝑑𝑒𝑟   
               (3.1) 
 
where Im(x,y,z) is the image intensity of pixel (x,y,z); 1central (Im(x,y,z) < Tc) is the indicator 
function for pixels within the central cylinder and of low image intensity; 1shell (Im(x,y,z) > 
Tc) is the indicator function for pixels within the outer shell and of high image intensity . 
Step 3: Segmentation of clavicles anterior to the seeds 
The clavicle anterior to the seed is segmented by successive region growing in the 
inferior direction in the spatial region constrained by the segmented clavicle cross section on 
the superior axial level. For a pixel to be considered as clavicle, two inclusion criteria are 
employed during the region growing process: 
(i). It is a high-intensity pixel (intensity threshold Tc).  
(ii). It is connected to the segmented clavicle cross section on the superior axial level. 
The left and right seed points identified in step 1 are considered as two clavicle landmarks and 
denoted by LCL and LCR respectively as shown in Figure 3.1. 
3.1.1.2 Sternum segmentation and labeling 
The sternum is located in the medial and anterior thoracic cavity, and consists of three 
main parts as shown in Figure 3.3 (a): the manubrium, the sternal body and the xiphoid 
process. As sternum is connected to the clavicles at sternoclavicular joint as shown in Figure 
3.1, a seed axial cross section of the sternum can first be obtained by identifying the most 
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superior high intensity pixels (intensity threshold Ts) that are medial and anterior to the 
clavicle landmarks LCL and LCR as shown in Figure 3.3 (b). Then the same region growing 
approach as described in section 3.1.1.1 is applied to segment cross sections in the superior 
and inferior direction respectively, starting from the seed axial cross section.  
The existence of calcified cartilages is typically considered as the greatest challenge 
for the sternum segmentation [50] as they can be of the similar image intensity and closely 
connected to the sternum as shown in Figure 3.3 (c-d). The sternum segmentation algorithm 
takes into consideration that the cartilages only join the sternum in the costal space while 
there is usually well-defined sternum axial cross section in the intercostal space as shown in 
Figure 3.3 (a, c-e). During the successive region growing in the inferior direction, the lateral 
spatial limit of the sternum cross section can be defined based on the segmented sternum cross 
section on the superior axial level. If on current axial level, the segmented cross section 
exceeds the lateral limits, it suggests the existence of calcified cartilages and unreliable 
segmented cross section on current axial level (costal space). In such case, only high intensity 
pixels within the projection of previously segmented cross section are considered as sternum. 
The current sternum segmentation algorithm is based on our previous published work 
[50], which was originally evaluated in 351 scans and demonstrated some segmentation issues 
when extending to the larger validation set of 1270 scans. The new algorithm takes advantage 
of the segmented clavicles to provide a reliable spatial reference to the superior end of the 
sternum and the lateral constraints to avoid the inclusion of adjacent calcified cartilages. The 
superior and inferior extent of the segmented sternum are considered as two landmarks and 
denoted by LSS and LSI respectively as shown in Figure 3.1. 
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Figure 3.3 (a) Coronal view of the sternum and ribs. The costal cartilages are shown in grey. 
(b) The clavicle (yellow) and seed axial cross section of the sternum (blue). (c-e) A example 
scan with significant calcified cartilages shown in (c) coronal view, in (d) axial view at the 
level of costal space, and in (e) axial view at the level of intercostal space.   
 
3.1.1.3 Rib segmentation and labeling 
The 24 individual ribs are segmented by first detecting a seed point for each rib; and 
then by 3D region growing starting from the detected seed within the constrained region 
adjacent to lungs. The rib segmentation algorithm is built upon our previous work [51], where 
the seeds are detected in the region lateral to the spinal canal. As noted in [51], that algorithm 
may fail to detect superior ribs either because the scan does not cover up to that superior level 
or the scan are extremely noisy at that axial level due to the existence of the shoulder bones. 
To address these issues, in the new approach, the seeds of the superior two ribs on each side 
of the body are detected at the centers of masses of the most superior bone components 
located near the anterior surface of the lungs as illustrated in Figure 3.4. The new seeds are 
inferior to those used in the original algorithm, thereby addressing the issues of scan coverage 
and high noise levels. The seed of each individual rib is considered as a rib landmark and 
denoted as LRRN and LLRN for the n-th right and left rib respectively.    
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Figure 3.4. The seeds (marked by the red crosses) for the right/left first and second ribs. The 
clavicle (yellow) and lungs (green) are also shown. 
 
3.1.1.4 Vertebra segmentation and labeling 
Vertebrae are bones with irregular shape and complex structures, which articulate with 
each other and form the spinal column in the back of the human body. A typical vertebra 
consists of the vertebral body and the vertebral arch, which together enclose the spinal canal 
as illustrated in Figure 3.5 (a).  
With the prior knowledge of the segmented sternum, ribs and lungs, the whole spine 
can be obtained based on image thresholding (at intensity Tv) and noise reduction filtering in 
the volume of interest that extends laterally to the ribs and lungs, and anteriorly to the 
sternum. Two consecutive vertebrae are subsequently separated from each other by fitting two 
dividing planes as shown in Figure 3.5 (b-d): one 3-layer plane anterior to the spinal canal for 
dividing the vertebral bodies; and the other single-layer plane posterior to the spinal canal for 
dividing the vertebral arches. 
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Figure 3.5.  (a) Two consecutive vertebrae and the intervertebral disc (yellow) between them. 
(b) The 3-layer dividing plane model. (c) The single-layer dividing plane model. (d) The 3-
layer plane model is fit in the region anterior to the spinal canal centerline and the single-layer 
plane model is fit in the region posterior to the spinal canal centerline. 
 
The model of the 3-layer anterior dividing plane consists of the middle layer 
representing low intensity (intensity threshold at Tv) intervertebral disc and the two layers on 
top and bottom representing the high intensity endplates of the consecutive vertebrae as 
shown in Figure 3.5 (b, d). The dimensions of the plane are defined by 4 pre-established 
parameters including the height h1 and h2, width w and length l as indicated in Figure 3.5 (b). 
The position and orientation of the plane are determined by optimizing 3 parameters as shown 
in Figure 3.5 (b, d), including the vertical position p, and two orthogonal bases b1 and b2 by a 
fitting procedure based on equation (3.2). 
p, b1, b2  =  argmax
𝑝,   𝑏1,   𝑏2
 ∑
1disc (Im(x,y,z)<Tv)  + 1endplate (Im(x,y,z)>Tv)  
(2ℎ1+ℎ2)𝑤𝑙  
(𝑥,𝑦,𝑧) 𝑤𝑖𝑡ℎ𝑖𝑛 
𝑡ℎ𝑒 𝑝𝑙𝑎𝑛𝑒   
            (3.2)                        
where the matching score is defined as the sum of the percentage of low-intensity pixels 
contained in the disc layer and the percentage of high-intensity pixels contained in endplate 
layers. Similar in equation (3.1), 1disc (:) and 1endplate (:) are indicator functions for pixels in the 
disc layer and endplay layers respectively. 
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The single-layer posterior dividing plane is used to model the low intensity soft tissue 
between two consecutive vertebral arches. Similar to the 3-layer model, it is defined by 6 
parameters, including 3 pre-established parameters as specified in Figure 3.5 (c), height h, 
width w, and length l, for the dimensions, and 3 other parameters, p, b1 and b2, to optimize 
based on equation (3.3) for the determination of the position and orientation.  
p, b1, b2  =  argmax
𝑝,   𝑏1,   𝑏2
 ∑
 1(Im(x,y,z)<Tv)  )  
ℎ𝑤𝑙  
(𝑥,𝑦,𝑧) 𝑤𝑖𝑡ℎ𝑖𝑛 
𝑡ℎ𝑒 𝑝𝑙𝑎𝑛𝑒   
                       (3.3) 
The segmented thoracic vertebrae are labeled with their anatomical names, thoracic 
vertebra 1, …, thoracic vertebra 12, based on their spatial relationships with the labeled ribs. 
The centers of mass of the 12 thoracic vertebrae are considered as 12 vertebra landmarks and 
denoted as LV1, LV2, …, LV12. The cervical vertebrae and lumbar vertebrae that are superior 
and inferior the thoracic vertebrae are also labeled accordingly. The number of cervical 
vertebrae and lumbar vertebrae varies depending on the scan vertical range. 
3.1.2 Experiments 
The bone segmentation and labeling framework was validated using 1270 non-contrast 
LDCT chest scans from ELCAP [68], LIDC [69] and FAMRI datasets that were acquired 
generally for the purpose of lung cancer screening. The Validation by Visual Evaluation and 
Quantitative Revision (VEQR) [63, 4] was employed to evaluate the performance based on 
both 2D and 3D visualizations as shown in Figure 3.6-3.9.  
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Figure 3.6. Visualizations used for the evaluation of the segmentation and labeling for 
clavicles. (a, b) Coronal and axial views for the clavicles (pink) and reference bones (gray). 
(c, d) Axial slices for the right and left landmarks (red crosses). 
 
Figure 3.7. Visualizations used for the evaluation of the segmentation for sternum. (a, b) 
Coronal and sagittal views for the sternum. (c, d, e) Axial slices for the seed, superior end and 
inferior end of the sternum (green). 
 
For the clavicles, the segmentation is visualized in 3D coronal view and axial view 
respectively with the bone segmentation (obtained by image thresholding and noise reduction) 
also shown as reference in Figure 3.6 (a, b). The clavicle landmarks LCL and LCR for left and 
right clavicles are visualized in 2D axial view in Figure 3.6 (c) and (d) respectively. For the 
sternum, the segmentation is visualized in 3D coronal view and sagittal view respectively in 
Figure 3.7 (a, b). The seed point, and two sternum landmarks LSS and LSI, are visualized in 2D 
axial view respectively in Figure 3.7 (c-e). For the ribs, the segmentation and anatomical 
labels are visualized in 3D coronal view with 24 rib landmarks also shown in Figure 3.8 (a). 
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The superior end of the right and left rib segmentation are shown in 2D axial views in Figure 
3.8 (b, c) for the further verification of the anatomical labeling. For the vertebrae, the 
segmentation and anatomical labeling are visualized in 3D coronal view and sagittal view 
respectively in Figure 3.9 (a, b). The rib labeling is also visualized in transparent in Figure 3.9 
(a) to serve as a reference for the verification.  
 
Figure 3.8. Visualizations used for the evaluation of the segmentation and labeling for ribs. 
(a) Coronal view for ribs and landmarks (white dots). (b, c) Axial slices for the right/left 
superior ribs.  
 
Figure 3.9. Visualizations used for the evaluation of the segmentation and labeling for 
vertebras. (a, b) Coronal and sagittal views for vertebrae. The labeled ribs are also shown in 
transparent colors as reference. 
 
The results are considered as unacceptable if segmentation issues (including under-
segmentation and over-segmentation) or labeling issues occur and may influence the 
 54 
 
correctness of the corresponding landmark detection and the potential further analysis of the 
succeeding bone structures.  
3.1.3 Results 
The success rates from visual inspection for the bone structure segmentation and 
labeling framework in terms of clavicle, sternum, individual ribs and individual vertebrae 
segmentation and labeling are summarized in the Table 3.1.  
Table 3.1 Success rates (of 1270 cases in total) for the bone structure segmentation and 
labeling framework. 
 Segmentation Labeling 
Clavicles 97.1% 97.1% 
Sternum 97.3%  
Ribs 97.2% 94.2% 
Vertebra 92.4% 89.9% 
 
3.1.4 Discussion 
The success rates for the segmentation of individual bone structures were all above 
90% as shown in Table 3.1. Especially for the segmentation in first three stages, the presented 
framework achieved satisfactory results in more than 97% cases, demonstrating the reliable 
and robust performance. Examples of unacceptable segmentation for clavicles, sternum and 
ribs are shown in Figure 3.10, 3.11, and 3.12 respectively. These illustrate two major causes 
for the unusable results in the first three stages: (1) the existence of metal implants as shown 
in Figure 3.10, which violates the assumptions about normal anatomy and has not been taken 
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into consideration by the current algorithm so far; (2) a high level of image noise leading to 
low local contrast of bone structures as shown in Figure 11-12, thus causing the under-
segmentation of bones.  
 
Figure 3.10. An example of unacceptable clavicle segmentation due to the existence of metal implant. 
 
Figure 3.11. An example of unacceptable sternum segmentation due to high level of image 
noise. 
 
Figure 3.12. An example of unacceptable rib segmentation due to high level of image noise. 
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 The performance of labeling is in general inferior to the performance of segmentation, 
since any segmentation issue will necessarily influence the consequent step of labeling, thus 
leading to a labeling issue. Moreover, a successful segmentation does not guarantee a 
successful anatomical labeling. The example shown in Figure 3.13 shows that, although the 
rib segmentation is successful as indicated in Figure 3.13 (a), the rib anatomical labeling is 
incorrect due to the assumption that the left nth rib and right nth rib are, in general, located at 
the same axial level (not true for the 4th ribs in the example). Note that the performance for 
the clavicle segmentation and labeling is the same, because the clavicle labeling only involves 
determining left and right side which is trivial given a successful segmentation.  
The success rate in the final stage, vertebra segmentation and labeling, is the worst 
because of two primary reasons: First, the final stage is built upon the previous stages; 
therefore, any segmentation or labeling issue occurring in the previous stages is accumulated 
in the final stage as shown in Figure 3.13, where the rib labeling issue leads to an unusable 
vertebra labeling although the vertebra segmentation is initially correct. Second, the whole 
spine is of variable curvature along the vertical direction and each vertebra consists of a 
number of anatomical components with irregular shapes as shown in Figure 3.5 (a), which 
makes it more challenging to model compared to the other three bone structures with 
relatively well-defined shape and fewer nearby structures of similar image intensities. The 
framework is arranged in the order of increasing difficulty so that the target structures 
segmented first can be used as spatial priors for the structures segmented later. An 
unacceptable example of vertebra segmentation and labeling is shown in Figure 3.14.  
 To resolve the issues discussed above, there are several possible directions of the 
future work. First, metal implants need to be taken into consideration to avoid being confused 
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with bone structures. Second, the image intensity related algorithm parameters need to be 
optimized for individual scan instead of being constant across all scans with different levels of 
noise and radiation dose, as well as various types of reconstruction methods, filtering kernels 
and CT scanners.  
 
Figure 3.13. An example of acceptable (a) rib segmentation (a) but unacceptable (b) rib 
anatomical labeling, which also leads to unacceptable (b, c) vertebra labeling. 
 
Figure 3.14. An example of unacceptable vertebra segmentation and labeling where the 
dividing planes are incorrect. 
 
3.1.5 Conclusion 
The automated segmentation and labeling of the individual bone structures are 
essential for the automated measurement of skeletal characteristics and the detection of 
abnormalities. It can potentially provide a relatively reliable location reference to other non-
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rigid human organs and aid the image registration. A fully automated anatomy-directed 
framework for the segmentation and labeling of the individual bone structures including both 
clavicles, sternum, all ribs and thoracic vertebrae from LDCT is presented. The framework 
was validated with 1270 non-contrast LDCT images and visual evaluation results are 
encouraging for use in a fully automated image analysis context. 
3.2 Bone mineral density quantification from low-dose chest CT 
Osteoporosis is the most common metabolic bone disease and is estimated to affect 
12.3 million US population aged 50 years or older in 2020 [18]. The prevalence of 
osteoporosis is continuing to increase rapidly with the progressively aging populations [20]. 
Osteoporosis is characterized by low bone density and micro-architectural deterioration of 
bone tissue [19] with related complications, such as osteoporotic fractures, becoming a 
significant cause of increased morbidity and mortality [20, 70], and thereby creating 
tremendous social and economic burdens. It is estimated by Burge et al. [71] that there are 
more than 2 million new osteoporotic fractures in the US every year, incurring more than $20 
billion in costs. As osteoporosis is a silent disease and often undetected until a fracture occurs, 
the early diagnosis of osteoporosis is crucial for timely treatment and risk assessment for 
osteoporotic fractures [20, 70]. 
The assessment of bone mineral density (BMD) is central in the diagnosis and follow-
up therapy monitoring of osteoporosis as well as other metabolic bone diseases [72]. 
Osteoporosis was defined by World Health Organization (WHO) [19] based on the 
measurement of areal bone mineral density (aBMD) (g/cm2) at either the femoral neck or the 
lumbar spine using dual-energy X-ray absorptiometry (DXA), which is currently the most 
 59 
 
widely used and gold standard technique for the diagnosis of osteoporosis and fracture risk 
estimation [72].  
Computed tomography (CT) has also been applied to quantify BMD by providing 
separate volumetric bone mineral density (vBMD) measurements of trabecular and cortical 
bone, which is generally considered more accurate than two-dimensional DXA aBMD 
measurements that cannot distinguish between cortical and trabecular bone and can be 
distorted due to spinal degenerative changes (such as compression fracture, osteoarthritis, 
osteophytes and degrading vertebral disks), deformity or calcifications located near the spine 
such as aortic calcification [72, 70]. Both calibrated [73, 74, 75, 76, 77, 78, 79, 80, 81], and 
uncalibrated [73, 75, 77, 82, 83, 84, 85, 77, 86, 87] [88] vBMD obtained from CT have been 
shown to correlate well with aBMD obtained from DXA and be able to aid the diagnosis of 
osteoporosis and the detection of vertebral compression fracture. Calibrated vBMD can be 
obtained by using either an external reference phantom scanned with the patient [74, 73, 75, 
76, 78, 89] or soft tissue (fat or muscle) of the patient as internal reference [77, 74, 76, 79] to 
derive the calibration equation to convert the CT attenuation in Hounsfield units (HU) to 
vBMD in milligrams of calcium hydroxyapatite per cubic centimeter (mg/cm3). Uncalibrated 
vBMD expressed in HU has been demonstrated in several recent studies [73, 75, 77] to have 
no statistically different diagnostic performance compared to calibrated vBMD, suggesting 
the feasibility of using routine CT without calibration phantom for opportunistic BMD 
assessment and osteoporosis screening. As the chest LDCT in general also covers the regions 
of thoracic vertebrae T1-T12 and lumbar vertebrae L1-L2, it has the potential to serve as an 
opportunistic osteoporosis screening modality 21 as other routine CT obtained for clinical 
indications other than bone densitometry [87, 73, 75, 77, 80].  
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Previous studies [89, 73, 74, 75, 76, 77, 78, 82, 83, 84] [85, 77] on BMD assessment 
from CT mostly focus on measurement within 2D axial region of interest (ROI) placed 
manually in the trabecular region of the vertebral bodies. 3D volumetric ROI has been 
employed in recent studies [79, 80, 86, 88], which has been shown to provide more reliable 
measurements with greater reproducibility and correlation with aBMD measured from DXA 
(BMDDXA) compared to 2D ROI [79, 86]. Tay et al demonstrated that using both trabecular 
and cortical bone can achieve better correlation with BMDDXA in [79]. Fully automated BMD 
assessments from CT (BMDCT) have been presented by Summers et al. for CT colonography 
[80], by Tay et al. for routine abdominal CT [79], by Zhou et al. for whole body CT [81], and 
by Burns et al. for CT with spine protocol [88]. 
 The purpose of this study is to present a fully automated system for the BMD 
assessment based on image attenuation (HU) from the LDCT acquired during annual lung 
cancer screening using BMDDXA measured from DXA as the reference standard. BMDCT 
measurements of both trabecular and a combination of cortical and trabecular vertebral bodies 
at different vertebral levels were investigated by exploring various 3D volumetric region of 
interest (ROI) for the assessment. Our hypothesis is that BMDCT can be obtained fully 
automatically from LDCT with statistically significant strong correlation with BMDDXA, 
demonstrating the potential of opportunistic osteoporosis screening with concurrent lung 
cancer screening using LDCT.  
3.2.1 Methods 
The presented framework for BMDCT assessment consists of three main stages as 
illustrated in Figure 3.15. First, the individual vertebra is segmented and labeled with its 
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anatomical name (n-th thoracic vertebra as Tn and n-th lumbar vertebra as Ln) using 
anatomical-directed knowledge-based approach that was presented in the previous section 3.1. 
Second, the vertebral body with closed 3D surface is then segmented using progressive 
surface resolution (PSR) algorithm by considering both image intensity and surface geometry. 
Third, a 3D volumetric region of interest (ROI) within each segmented vertebral body is 
determined for the mean CT attenuation measurement. 
 
Figure 3.15. Flow chart illustration of the presented system for BMDCT assessment. The 
segmentation and anatomical labeling of vertebrae in which the first three lumbar vertebrae 
are visible in (a) coronal view with ribs shown in transparent colors and in (b) sagittal view. 
The segmented individual vertebra and vertebral body (green) shown in (c) axial view and (d-
e) sagittal view. The ROI (green) for BMDCT measurements shown in (f) sagittal view and (g) 
axial view. 
 
3.2.1.1 Segmentation of vertebral body with 3D closed surface 
The segmentation of a vertebral body with 3D closed surface as shown in Figure 3.15 
(c-e) is achieved using progressive surface resolution (PSR) algorithm that was previously 
presented in [90], which is a generic algorithm designed to segment the surface of 
approximately convex blob-like structures. The PSR algorithm requires an intensity image 
and a high confidence boundary image (which can be acquired automatically using simple 
methods such as 3D edge detection) as inputs. The target surface is realized by a closed 
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triangular mesh, which therefore guarantees the enclosure of the surface. The surface vertices 
on the triangular mesh are constrained along radial trajectories that are uniformly distributed 
in the 3D angle space, emanating from the centroid of the input high confidence boundary. 
The segmentation is accomplished by sequentially resolving each surface vertex on the 
respective radial trajectory according to a dynamic attraction map that incorporates the prior 
knowledge of the vertebral cortical surface regarding its intensity, the smoothness and the 
geometry. 
The PSR algorithm consists of three main steps. First, trajectories are generated using 
rays emanating from the centroid of the input high confidence boundaries. Second, the surface 
is initialized based on intersections between the trajectories and the input high confidence 
boundaries. Third, sequential surface resolution is performed based on a dynamic attraction 
map, which describes the magnitude of the attraction potential P(p) that is intended to 
measure the attraction at an image point p to the target surface we seek to segment. The 
definition of attraction potential P(p) takes account of intensity, smoothness and shape 
constraints. It is dynamically updated by incorporating the location of newly resolved surface 
vertices, and then is used to resolve other unknown vertices. Each surface vertex is 
constrained along a unique radial trajectory and resolved in an order of decreasing degree of 
evidence regarding the target surface without involving any iterative refinement. This novel 
resolution strategy provides uniform angular resolution for the segmented surface with 
computation complexity and runtime that are linearly constrained by the total number of 
vertices on the triangular mesh. 
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Figure 3.16. Flow chart illustration of the segmentation of vertebral body with 3D closed 
surface. (a) vertebra segmentation. (b) A high confidence boundary image B of the vertebral 
body as input to PSR algorithm. (c) Illustration of the separation between vertebral body and 
posterior part of the vertebra. (e-f) Initial surface generation. Resolved 3D closed surface of 
the vertebral body represented as triangular mesh (g) and green region (d) overlaid the input 
B.  
 
 A high confidence boundary image B of the vertebral body is required as the input to 
the PSR algorithm to provide the centroid C and to initialize the surface, as illustrated in 
Figure 3.16 (b). B is obtained based on the following two steps. First, individual thoracic 
vertebra and the centerline of spinal canal are obtained following methods described in 
previous section 3.1, as illustrated in Figure 3.16 (a, c). Second, the vertebral body is 
separated from the spinal processes by analyzing the intensity profile along the anterior-
posterior direction as illustrated in Figure 3.17. The boundary image B is then generated by 
removing the spinal processes from the vertebra segmentation as shown in Figure 3.16 (b, c), 
and the centroid C is determined automatically by computing the center of mass of B. The 
input boundary image B may contain spurious high intensity components in the trabecular 
bone and holes on the cortical surface as illustrated in Figure 3.16 (b). 
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Figure 3.17. Determination of the dividing plane that separates the vertebral body and the 
spinal processes. The tangent of the SCC and three example plane candidates p1, p2, p3 are 
shown in (a) sagittal view and (b) in axial view. Only the region of a lateral width of 14 mm 
are used to compute the intensity profile H(p) as illustrated by the shaded region in (b). (c) An 
example intensity profile. 
 
The separation between the vertebral body and the spinal processes is accomplished 
by determining a dividing plane that is parallel to the tangent of the spinal canal centerline 
(SCC). An intensity profile H(p) is first defined as follows for any plane p that is anterior and 
parallel to the tangent of the SCC.  
H(p) = ∑   𝑰(𝑣)𝑣 ∈ 𝑝,   𝑑𝑖𝑠𝑡𝑥 (𝑣,   𝑆𝐶𝐶) ≤  7 𝑚𝑚 ,     ∀ 𝑝 ∈   𝑻                      (3.4) 
Where I (v) is the interpolated image intensity of point v, which is sampled with resolution 0.5 
mm x 0.5mm from plane p; distx(v, SCC) is the lateral distance between v and the SCC; T is 
the set of all planes that are anterior and parallel to tangent of the SCC, where the separation 
between adjacent planes is 0.5 mm. Thus the intensity profile H(p) is computed by summing 
interpolated image intensities within a lateral width of 14 mm on each dividing plane 
candidate p as illustrated in Figure 3.17. The dividing plane p* is then determined as follows: 
p * =   𝑝
𝑎𝑟𝑔     𝑚𝑖𝑛   𝑑𝑖𝑠𝑡(𝑝,   𝑆𝐶𝐶),     𝑝 ∈ 𝑻  𝑎𝑛𝑑  𝑯(𝑝) >0.5 𝐻𝑀𝑎𝑥                         (3.5) 
Where dist(p, SCC) is the distance between the plane candidate p and the SCC, HMax is the 
maxima of the intensity profile. Therefore, p* is in fact the most posterior plane with sum 
intensity larger than 50% shoulder of the profile. An example intensity profile is shown in 
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Figure 3.17 (c), where several dividing plane candidates have been marked by dashed line, 
and p1 is the selected dividing plane.  
 A closed triangular mesh is used to realize the vertebral surface and thereby 
guarantees the enclosure of the surface. The surface vertices on the triangular mesh are 
constrained along radial trajectories that are uniformly distributed in the 3D angle space. The 
trajectories are generated following two steps. First, the approximate centroid C of target 
structure is obtained by computing the center of mass of the input high confidence boundary 
B. Second, project rays from C through vertices of a triangular tessellated icosahedron 
centered at C as shown in Figure 3.16 (e). Higher spatial resolution for the segmented surface 
is easily attained by subdividing each equilateral triangular face of the icosahedron into 
smaller equilateral triangular elements as shown in Figure 3.16 (f). 
 
Figure 3.18. Neighbor set N(p) of image point p located along trajectory r. The neighboring 
vertices of p, i.e., vertices in N(p), are marked by triangles in (b). 
 
The surface mesh is initialized based on the intersections between radial trajectories 
and input high confidence boundary B as summarized in Algorithm 1. For each trajectory 
intersecting B, the location of the corresponding vertex is resolved according to the respective 
intersections, and considered to belong to the target surface with high confidence, with 
additional geometry constraints to reject intersections between trajectories and spurious 
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boundaries (i.e., boundaries representing high interior regions instead of the cortical surfaces 
in B).  The resolved set S is then initialized using these vertices. The vertices that are 
undermined yet constitute the unresolved set F (i.e., SC). The surface is then initialized by 
constructing the triangular mesh representation of vertices in S with respective neighboring 
relations defined by the trajectories. If F ≠ ∅, the initial surface is not close yet. However, 
after the subsequent surface resolution process, all vertices in F will be resolved in an ordered 
sequence, and a closed triangular mesh representation of the target surface will be achieved as 
shown in Figure 3.16 (g). 
Algorithm 1 Surface initialization 
/* Initialize the resolved set S and unresolved set F */ 
S  ← { arg
𝑝  
max  dist(p, C ),  p ∈ r and p ∈ B  | ∀ r ∈ R }              
 
F  ← S C 
 
 
/* Reject intersections with low GNI or CI*/ 
done ← 0 
while done = 0 do 
done ← 1 
 
for each v ∈ S  do 
if  GNI(v) < r1  or  CI(v) < r2  do 
        remove v from S, add v into F 
             done ← 0 
       end if 
end for 
 
end while 
 
 
The geometry constraints are introduced based on the assumptions that the target 
structure is nearly convex and the surface is smooth in the local neighborhood. We employ 
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two metrics, the good neighbor index (GNI) defined in (3.6) and the convexity index (CI) 
defined in (3.7), to reject intersections. 
GNI(v) =   
 | { 𝑣′| 𝑣′ ∈ 𝑵(𝑣),   𝑣′ ∈  𝑺 }  |
| 𝑵(𝑣)  |
 ,    for v ∈ F                           (3.6) 
Where | A | is the number of elements contained in set A; N(p) is the set of neighboring 
surface vertices of p. If we let r denote the trajectory associated with p, i.e. p ∈ r, N(p) 
consists of surface vertices located along neighboring trajectories, which are connected to r by 
edges on the surface mesh, as illustrated in Figure 3.18. 
 CI(v) =   
dist(𝑣,   𝑪 )
max 
𝑣′ ∈ 𝑵(𝑣)
dist(𝑣′,   𝑪 )
                                             (3.7)              
Where dist(v’, C) is the Euclidean distance between vertex v’ and the centroid C. Note that for 
an unresolved vertex v’ (i.e., v'  ∈ F ), its distance to C should assume the local maximal 
distance from nearby resolved vertices to C, so that the geometry information is passed 
through the unresolved vertices to the neighboring resolved vertices. This can be ensured in 
the implementation by assigning a local maximal distance to any vertex newly added to F.     
 As a consequence, an intersection v between the trajectory and B is rejected if most 
neighboring trajectories have no intersections (i.e., GNI(v) is low) or the distance from v to 
the centroid C is significantly shorter than that from neighboring vertices (i.e., CI(v) is low). 
A low GNI(v) indicates the region around v is noisy and unreliable, thus v should not be 
considered as part of the robust boundary; a low CI(v) indicates that v introduces severe 
concavity into the surface, which violates the convexity assumption about the target structure. 
The surface segmentation is accomplished by sequentially resolving all vertices in the 
unresolved set F according to the dynamic attraction map. The vertices with the most 
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evidence regarding the target surface are resolved first and then are incorporated to update the 
attraction map for the resolution of the remainder of the vertices in F.  
The dynamic attraction map describes the magnitude of the attraction potential P(p), 
which is intended to measure the attraction at an image point p to the target surface we seek to 
segment. Note that the image point p is not equivalent to the image voxel, because it is 
sampled along each trajectory in continuous space with desirable sampling distance for the 
specific task structure, i.e., the potential P(p) is not defined on the voxel grid. The potential P 
incorporates the prior knowledge of the target surface regarding the intensity PI, the 
smoothness PS and the geometry PG. The attraction map is dynamic because the newly 
resolved vertices are incorporated to update the smoothness term PS and geometry term PG of 
the potential, thereby sequentially imposing more appropriate and complete constraints on the 
surface resolution. 
 An example definition of the attraction potential P(p) at image point p is given as 
follows:  
P(p)  =  𝛼  PI (p)  + 𝛽 PS (p, S) + 𝛾 PG (p, S) ,     ∀  p ∈ r ∈ U                  (3.8) 
𝛼 + 𝛽+ 𝛾 = 1                                                          (3.9) 
0 ≤ 𝛼, 𝛽, 𝛾 ≤ 1                                                        (3.10)                                                              
Where the potential is considered as a weighted sum of the intensity term PI, the smoothness 
term PS and the geometry term PG with weights 𝛼, 𝛽 and 𝛾 respectively; U is the set of 
unresolved trajectories and S is the set of resolved vertices. Note that the potential P(p) is only 
defined for image point p located along an unresolved trajectory r, because for resolved 
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trajectories, the associated surface vertices have already been determined, thus the potential is 
not needed.   
The intensity term PI (p) is designed to have a large value if the image point intensity 
I(p) is close to the expected intensity of the target surface. Note that I(p) is obtained based on 
trilinear interpolation of the input intensity image, because p may be located between image 
voxels. If we assume that the surface intensity is generally higher than that of the interior and 
exterior regions, an example definition of PI (p) is given as follows: 
PI (p) =   𝑒
  − max(0,   𝜏−I(𝑝))2 
2 𝜎1
2  
                                             (3.11) 
Where 𝜏 is the intensity threshold; 𝜎1 is the parameter used to control the potential penalty for 
points with low intensities. However, if the target surface has generally lower intensity than 
the surrounding regions, (3.11) needs to be modified as: 
PI (p) =   𝑒
  − max(0,   I(𝑝)− 𝜏)2 
2 𝜎1
2  
                                           (3.12) 
The smoothness term PS (p, S) is defined based on the assumption that target surface is 
smooth enough in the local neighborhood, suggesting that surface vertices tend to be close to 
each other. An example definition is given as: 
PS (p, S) =  𝑒
 − dist(𝑝,   𝑺)2 
2 𝜎2
2  
                                             (3.13) 
Where dist(p, S) is the Euclidean distance between p and the nearest resolved vertices in S; 𝜎2 
is the parameter used to control the potential penalty for points far away from resolved surface 
vertices.  
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The geometry term PG (p, S) incorporates the prior knowledge that the target surface is 
approximately convex by penalizing points with significantly shorter distance to the centroid 
C than resolved neighboring vertices. An example geometry term is defined as follows: 
PG (p, S) = min (  
𝑑𝑖𝑠𝑡(𝑝,   𝑪 )
max 
𝑝′ ∈ 𝑵(𝑝), 𝑝′ ∈ 𝐒
𝑑𝑖𝑠𝑡(𝑝′,   𝐂 )
 , 1 )                             (3.14) 
Where dist(p, C) is the Euclidean distance between p and the centroid C; N(p) is the set of 
neighboring surface vertices of p as used in (3.6). 
The sequential surface resolution, as summarized in Algorithm 2, resolves one vertex 
v from F per step by determining the location p with maximal potential P(p) along the 
respective trajectory r(v). The order of resolution depends on the amount of local information 
regarding the target surface. A region with more resolved neighboring vertices provide more 
evidence of the target surface, because both the smoothness term PS and the geometry term 
PG, defined in (3.13) and (3.14) respectively, reply on the resolved neighboring vertices. 
Therefore, the surface resolution is performed in a decreasing order of GNI as defined in 
(3.6).  
Algorithm 2 Sequential surface resolution      
while | F | > 0 do      
maxGNI ← max 
𝑣 ∈ 𝑭
GNI(𝑣) 
 
for each v ∈ F  and  GNI(v) =  maxGNI do  
 
        v ← arg
  𝑝   
max P(p) ,    p ∈ r (v) 
 
          remove v from F , add v to S 
     end for 
 
 update GNI(v) for each vertex v ∈ F   
end while    
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3.2.1.2 ROI determination for mean CT attenuation measurement 
Two types of 3D volumetric region of interest (ROI) within each segmented vertebral 
body, corresponding to 1) trabecular bone tissue only (ROIT) and 2) both trabecular and 
cortical bone tissues (ROIC), as illustrated in Figure 3.19 (a-b), have been explored. Previous 
studies [73, 74, 75, 76, 77, 78, 80, 82, 83, 84] [85, 77, 86, 88, 89] on BMD assessment from 
CT mostly focus on a trabecular ROI, since trabecular bone tissue is metabolically more 
active and thus the main determinant of compressive strength in the vertebrae compared to 
cortical bone tissue [72]. Cortical BMD is included in the measurement of ROIC, which is 
expected to better correlate with the reference standard BMDDXA, because BMDDXA is a 
compound measurement of both cortical and trabecular BMD. 
 
Figure 3.19. 3D volumetric regions of interest within segmented vertebral body. (a) ROIC 
(green) consists of both trabecular bone tissue and cortical bone. (b) ROIT (green) consists of 
trabecular bone tissue only. tissue. (c) ROIC (dC = 3mm) and (d) ROIT (dT = 4 mm) shown in 
green on top of an axial slice of LDCT. 
 
 ROIC is defined as the outer shell of the vertebral body that is within distance dC to the 
segmented cortical surface as illustrated in Figure 3.19 (a). ROIT is determined by excluding 
outer shell of the vertebral body that is within distance dT to the cortical surface as illustrated 
in Figure 3.19 (b). The cortical thickness of human vertebral body is often less than 0.4 mm 
[91], whereas the spatial resolution of LDCT are typically larger than 0.5 mm, thereby 
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causing severe partial volume artifacts at the cortical surface. In order to avoid the distortion 
of measurement at the surface of the vertebral body, pixels within axial distance dA or vertical 
distance dV to the segmented cortical surface are excluded from the ROI. In addition, it is 
infeasible to extract an ROI consisting of only cortical bone tissue from LDCT, and all the 
presented ROIC in this paper are in fact a mixture of both cortical and trabecular bone tissue. 
Examples of ROIC and ROIT are shown in Figure 3.19 (c-d). 
3.2.2 Experiments 
The segmentation of vertebral bodies by the PSR algorithm was evaluated both 
qualitatively and quantitatively. A reference level set approach was also applied to the same 
set of vertebral bodies and compared to the PSR algorithm quantitatively in terms of 
segmentation accuracy, computation complexity and runtime. The presented BMDCT 
assessment framework was validated using the BMDDXA as reference standard.  
3.2.2.1 Evaluation of the vertebral body segmentation  
The PSR algorithm was applied to segment the cortical surfaces of 460 thoracic 
vertebral bodies from the VIA-ELCAP public database, which consists of 50 low-dose chest 
CT scans taken for the lung cancer screening purpose. For the evaluation of the algorithm, 4 
cases from the database were excluded, due to severe image artifacts caused by medical 
implants; 10 median vertebral bodies per CT image were segmented and evaluated, which 
constituted 460 vertebral bodies in total. A single GE CT scanner (GE LightSpeed Ultra, 
helical mode) was used with tube voltage of 120 KV and slice thickness of 1.25 mm. The in-
plane resolution ranges from 0.51mm to 0.82mm. The scans were preprocessed by a 3 x 3 x 1 
mean filter and clipped by the bounding box of the input high confidence boundary image B.  
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The surface was first initialized using Algorithm 1 as described in 3.2.1.1 with r1 = 
0.45 and r2 = 0.55, where the trajectories were generated by subdividing each face of an 
icosahedron into 64 smaller equilateral triangular elements, corresponding to 642 vertices of 
the triangular mesh representation. The progressive surface resolution was then performed by 
following Algorithm 2 with the attraction potential as defined in (3.8) – (3.14) with sampling 
distance of 0.5 mm, 𝜏 = 230 HU, 𝜎1= 50, 𝜎2= 8, 𝛼 = 0.3, 𝛽 = 0.4 and 𝛾 = 0.3.  These 
parameters were selected using an additional training set of 10 low-dose CT scans.  
 
Figure 3.20. The segmentation results were visually inspected in both (a, b) sagittal (the 
posterior spinal processes are also shown here as reference) and (c) axial view.  The 3D 
visualizations of (a) the input high confidence boundary image B and (b) the segmented surface 
(in green) are shown in the sagittal view. (c) The input CT overlaid with the interior region 
enclosed by the segmented surface (in transparent green) shown in the axial view. 
 
 
Figure 3.21 Manual annotations of the surface (yellow) used for quantitative evaluations: (a) 
upper axial slice, (b) median axial slice, (c) lower axial slice, and (d) median sagittal slice. 
 
The segmentation results were first visually inspected in both axial and sagittal views 
as shown in Figure 3.20. The input high confidence boundary image B and the resulting 
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segmentation of the vertebral body surface were compared using their 3D visualizations in 
sagittal view as shown in Figure 3.20 (a, b). For the axial view, the input CT scan was 
overlaid with the segmented interior region (i.e., region enclosed by the segmented surface 
shown in transparent green) at the median axial level as shown in Figure 3.20 (c). The 
segmentation was considered acceptable if the green regions generally overlapped the 
vertebral body with no obvious extra structures or missing parts, and there was no hole on the 
segmented surface. 
In addition to the qualitative validation, the segmented surfaces of 46 vertebral bodies 
(the median vertebra from each CT scan) were also evaluated quantitatively. Manual 
annotations of the cortical surfaces on the median sagittal slice and three axial slices (upper, 
median and lower axial slices) were used as the ground truth as shown in Figure 3.21. The 
upper (lower) axial slice was selected by locating the most superior (inferior) axial slice 
where more than 80% of the vertebral body cross section appeared. The agreement between 
the ground truth (G, the volume enclosed by the annotated surface) and the segmentation 
results (S, the volume enclosed by the segmented surface) was measured by the Dice 
coefficient (DC), which is defined as follows: 
DC = 
2 |𝑮  ∩  𝑺|
   |𝑮|+|𝑺|   
                                              (3.15) 
To compare the PSR algorithm with other alternatives, the 46 vertebral bodies used for 
quantitative evaluation of the PSR algorithm were also segmented using the level set 
approach, which was similar to the methods employed by Tan et al. [92]. The implementation 
was based on the ITK level set segmentation module [93] following the geodesic active 
contour model proposed by Caselles et al. [94]. 
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For a fair comparison, the same initial seed point and input gray level chest CT were 
used for both the PSR and level set method. The centroid C generated in section 3.2.1.1 was 
used as the initial seed point for the level set algorithm. The dividing planes described in 
section 3.2.1.1 for separating individual vertebra and for separating vertebral body from the 
posterior spinal processes were also used to select the volume of interest in the input CT 
scans. In addition to the seed point location, 14 parameters are required for the level set 
algorithm. These parameters were selected using an additional training set of 10 low-dose CT 
scans. The same quantitative evaluation method as described above was applied. 
Table 3.2 Pearson correlation coefficient between BMDDXA and BMDCT measurements at 
each vertebra level (T1 to L2) and for each ROI (1 to 8). dA =0.5 mm and dV =5 mm were 
used for all eight ROIs. The number of available vertebrae for BMD analysis are specified by 
n= at each vertebral level. The last three rows correspond to the average BMDCT 
measurements. All correlation coefficients are statistically significant (p-value < 0.001). 
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3.2.2.2 Evaluation of the BMDCT assessment framework 
The presented BMDCT assessment framework was validated using a dataset consisting 
of 76 pairs of DXA and LDCT scans of the same subject. Most of the subjects underwent the 
DXA and LDCT within 2 months (61% within 2 months; 9% between 2 months and a year; 
16% between a year and 2 years; and 14% > 2 years). The average aBMD (in g/cm2) of L1 to 
L4, BMDDXA, was obtained using the manufacturer-supplied software and GE Lunar iDXA 
DXA scanner in the postero-anterior view by a board-certified radiologist. All LDCT scans 
were acquired on Siemens CT. Various scanner models and reconstruction kernels were used.  
 Vertebral bodies were segmented and anatomical labeled from all 76 LDCT scans 
using the presented fully automated framework. Eight different ROIs, including four ROIT 
and four ROIC, as defined by the parameters (dT, dC, dA, and dV) specified in Table 3.2, were 
constructed for each segmented vertebral body. The mean CT attenuation in HU was 
measured within each ROI and considered as the corresponding BMDCT at the respective 
vertebral level. The average BMDCT of upper thoracic vertebrae T3-T8, lower thoracic 
vertebrae T9-T11, and lumber vertebrae L1-L2 were also calculated. The Pearson correlation 
coefficient was computed between each BMDCT measurement and the reference BMDDXA. P-
values < 0.001 were accepted as statistically significant.  
3.2.3 Results 
3.2.3.1 Evaluation of the vertebral body segmentation 
For the qualitative evaluation, the PSR algorithm was able to achieve acceptable 
surface segmentation of 99.35% (457 out of 460) vertebral bodies as shown in Figure 3.22 (a-
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c), whereas only 0.65% (3 out of 460) vertebral bodies were segmented incorrectly as shown 
in Figure 3.22 (d-f). 
The quantitative evaluation results of 46 vertebral bodies are summarized in Table 3.3. 
The automated segmentation is shown to be consistent with the manual annotated ground 
truth with the mean Dice coefficient (DC) larger than 0.93 on both the axial (including upper, 
median and lower) and the median sagittal slices.  Four examples of the segmentation with 
different DC values are shown in Figure 3.23. 
 
Figure 3.22 Three examples of acceptable segmentation (a-c) and three unacceptable cases 
(d-f). The arrows indicate the structures incorrectly segmented. 
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Figure 3.23 Four examples of the segmentation results. (a) DCL = 0.870, lower axial slice. (b) 
DCM = 0.975, median axial slice. (c) DCS = 0.834, median sagittal slice. (d) DCS = 0.980, 
median sagittal slice. 
 
The quantitative comparison results of the segmentation obtained by the PSR 
algorithm and the level set approach for 46 vertebral bodies are summarized in Table 3.4. The 
PSR algorithm was able to segment a vertebral body with a mean DC of 0.939 in 0.0443 
seconds on average; while the level set approach achieved the segmentation with a mean DC 
of 0.875 in 11.66 seconds on average. The paired t–test results for the DC measurements in 
Table 3.4 indicated that the PSR has a statistically significant improved segmentation 
performance compared to the level set method (p < 0.001) for each of the four DC measures. 
Table 3.3 The quantitative evaluations results for 46 vertebral bodies. Dice coefficient (DC) 
for the upper axial slice (DCU), the median axial slice (DCM), the lower axial slice (DCL) and 
the median sagittal slice (DCS) are reported below. 
 DCU DCM DCL DCS Mean 
Mean 0.933 0.946 0.936 0.942 0.939 
Max 0.963 0.975 0.962 0.980 0.957 
Min 0.872 0.906 0.870 0.834 0.906 
Standard Deviation 0.022 0.013 0.017 0.022 0.011 
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Table 3.4 The quantitative comparison results. The average Dice coefficient (DC) for the upper 
axial slice (DCU), the median axial slice (DCM), the lower axial slice (DCL), the median sagittal 
slice (DCS), the mean DC, and the average execution time (per vertebra) are reported below.  
 DCU DCM DCL DCS Mean DC Execution time 
PSR 0.933 0.946 0.936 0.942 0.939 0.0443 s 
Level set 0.873 0.864 0.885 0.876 0.875 11.66 s 
 
3.2.3.2 Evaluation of the BMDCT assessment framework 
The number of available vertebra bodies varies from scan to scan due to the difference 
in scan vertical coverage. As shown in the first column in Table 3.2, T2 – T11 are available 
for BMD analysis on all 76 scans; T12 is available on 94.7% of the scans; T1 is available on 
76.3% of the scans; L1 is available on 78.9% of the scans; L2 is available on 50% of the 
scans.  
The Pearson correlation coefficient between BMDDXA and BMDCT measurements at 
each vertebra level (T1 – L2) and for each ROI (1-8) are summarized in Table 3.2. The last 
three rows correspond to the average BMDCT measurements. All correlation coefficients are 
statistically significant (p-value < 0.001). The Pearson correlation coefficients between 
BMDCT and BMDDXA at different vertebra levels using the best ROIT (ROI 1) and best ROIC 
(ROI 6) are shown in Figure 3.24 (a) and (b) respectively. The Pearson correlation 
coefficients between BMDDXA and the average BMDCT of T3-T8, T9-T12, and L1-L2 
respectively for all eight ROIs are shown in Figure 3.25.   
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Figure 3.24. Pearson correlation coefficient between BMDCT and BMDDXA at different 
vertebra levels for (a) trabecular ROI 1 and (b) cortical ROI 6. 
 
Figure 3.25. Pearson correlation coefficient between BMDDXA and average BMDCT of (a) T3-
T8, (b) T9-T11, and (c) L1-L2 for eight ROIs. 
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3.2.4 Discussion   
Both qualitative and quantitative validations of the vertebral body surface 
segmentation demonstrate the robustness and promising performance of the PSR algorithm. 
The primary reason caused the 0.65% (3 out of 460) incorrect surface segmentation was 
external calcifications, i.e., left rib in Figure 3.22 (d) and aorta calcifications in Figure 3.22 (e, 
f), which are located very close to the vertebral body and are incorrectly included in the input 
high confidence boundary B. For the attraction potential and the surface initialization rules, 
there is an underlying assumption that B provides no significant calcifications other than the 
target vertebra itself. Therefore, the algorithm is capable of dealing with the spurious 
boundaries in the interior region and the holes on the cortical surfaces; however, it is not 
designed to perform robustly when B contains significant calcifications outside the vertebra, 
which is the case as shown in Figure 3.22 (d-f). Fortunately, the automated method we 
employed to obtain B provides high confidence boundaries satisfying the above assumption in 
almost all cases (99.35%, 457 out of 460). 
Additional modifications to the presented PSR algorithm are required to further refine 
the three unacceptable cases shown in Figure 3.22 (d-f). This issue may be addressed either by 
additional preprocessing to remove these structures prior to algorithm execution or by 
modifying the vertebra specific modifications to the PSR algorithm. The latter can be 
achieved by new distance exclusion rules for large distances or by adding additional factors to 
the attraction potential formulation. For the future, we will consider a larger dataset to collect 
sufficient cases with similar problem conditions, and explore the algorithm refinements 
mentioned above. 
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The PSR algorithm is able to provide a robust outcome with improved computation 
complexity (no iterations required), as compared to the deformable models that have been 
widely applied to segment a closed surface. The surface resolution process of the PSR is 
sequential, and the location of each vertex is optimized along a single radial trajectory. 
Therefore, the computation complexity and runtime are linearly constrained by the total 
number of vertices on the surface mesh (642 vertices employed in our implementation).  For 
our evaluation of the level set method shown in Table 3.4, this iterative method was more 
than 250 times slower than the proposed PSR algorithm. The outcomes for the level set 
method were inferior to the PSR method (average Dice coefficient of 0.875 compared to 
0.939). 
  As pointed out by Tan et al. [92], there are many parameters to be set for the level set 
method, which are difficult to tune. For algorithm optimization we individually varied all 
parameters through several iterations. The possibility of some improved performance with 
fewer algorithm iterations may be achievable. Also, incorporating multi-scale methods as 
suggested in the preliminary study [92] may address some of the leakage issues that were 
observed with the level set method. However, we observed a significant improvement with 
respect to speed and accuracy of our proposed method that is unlikely to be accounted for by 
parameter setting optimization.  
 BMDCT measurements obtained using the presented fully automated framework have 
been demonstrated to have strong statistically significant correlation, as shown in Table 3.2, 
with BMDDXA, which is currently the most widely used and gold standard technique for the 
diagnosis of osteoporosis and fracture risk estimation [72]. Among the four ROIT, the greatest 
correlation of 0.809 is obtained using the average BMDCT of the vertebra level T9-T11, which 
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is comparable to the best performance reported by Lee et al. in [85] (r=0.880 at L3 from 
abdominal routine CT scan) and by Kim et al. in [86] (r = 0.726 for average of T4, T7, T10 
and L1 from LDCT). The reason that our performance is worse than that reported by Lee et al. 
in [85] may be due to the much higher level of image noise in LDCT compared to routine 
abdominal CT in general.  
 BMDCT measurements including cortical bone tissue (i.e., using ROIC) have been 
demonstrated to have better correlation compared to just considering trabecular bone tissue 
(i.e., using ROIT), as shown in Table 3.2, Figure 3.24 and 3.25. Among the four ROIC, the 
greatest correlation of 0.857 is obtained between the average BMDCT of T9 –T11 and 
BMDDXA. All four ROIC are in fact a mixture of both cortical and trabecular bone tissue, 
which explains its greater correlation with BMDDXA that is also a compound measurement of 
both cortical and trabecular bone tissue. Similar results from routine abdominal CT have been 
presented by Tay et al [79]. Although better accordance with BMDDXA is obtained by 
including cortical tissue (mainly due to the inherent limitation of DXA scan), trabecular ROIs 
should be preferred for the BMD assessment from CT, since it is a more sensitive determinant 
of compressive strength in the vertebrae [72, 70].  
 The BMDCT measurements at lower thoracic vertebral levels (T9-T11) have, in 
general, better correlation with BMDDXA compared to BMDCT measurements at upper 
thoracic vertebral levels (T3-T8) and lumber levels (L1-L2), as shown in Table 3.2, Figure 
3.24 and 3.25. For instance, using ROI 6, the correlation between BMDDXA and average 
BMDCT of T9-T12 is 0.857, which is better than 0.823 using average BMDCT of T3-T8 and 
0.788 using average BMDCT of L1-L2. Since BMDDXA is measured from L1-L4, its 
correlations with BMDCT are expected to be higher at vertebral levels T9-T12 compared to 
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T3-T8, as observed by Miyabara et al [75] and Hayashi et al [78]. On the other hand, the 
lower correlation at lumbar vertebral levels L1-L2 may be caused by the much higher level of 
image noise that is often observed at axial levels inferior to lungs on the LDCT scans.    
With the recent large-scale implementation of annual lung cancer screening in the US 
using LDCT [10], great potential emerges for the concurrent extraction of quantitative image 
biomarkers from the chest regions other than lungs, such as heart [95], spine, ribs and breasts 
[45], which are also covered in LDCT scans. Kim et al. have demonstrated the feasibility of 
assessing BMD from LDCT using manually delineated ROI [86]. The results presented in this 
paper shows the feasibility of fully automated BMD assessment as well as the potential of 
osteoporosis diagnosis and vertebral compression fracture detection from LDCT acquired in 
the annual lung cancer screening. 
3.2.5 Conclusion 
A fully automated system is presented in this study for the BMD assessment based on 
image attenuation (HU) from the LDCT acquired during annual lung cancer screening. 
Average BMD of L1-L4 measured from DXA are used as the reference standard for the 
validation of BMDCT. Statistically significant (p-value < 0.001) strong correlation can be 
obtained between BMDDXA and BMDCT at all vertebral levels (T1 – L2). The highest Pearson 
correlation of 0.857 is achieved between BMDDXA and the average BMDCT of T9-T11 by 
using a 3D ROI considering both trabecular and cortical bone tissue. The encouraging results 
demonstrate the feasibility of fully automated quantitative BMD assessment and the potential 
of opportunistic osteoporosis screening with concurrent lung cancer screening using LDCT. 
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CHAPTER 4 
FULLY AUTOMATED AIRWAY LABELING AND QUANTITATIVE BIOMARKER 
MEASUREMENTS 
Chronic obstructive pulmonary disease (COPD), a heterogeneous disease associated with 
varying degrees of emphysema and small airways disease [21], is expected to be the 3rd 
leading cause of death by 2020 [22]. Several studies have established that airway dimensions 
(such as lumen diameter and wall thickness) are related to the airflow obstruction and 
peripheral airway inflammation in patients with COPD [96, 97, 98].  
Computed tomography (CT) is widely performed for patients with COPD [99]. The 
airway dimensions measured from CT chest scans have been demonstrated repeatedly to be 
correlated with measures of airflow obstruction [100, 101, 102, 103, 104, 105, 106, 107, 108]. 
CT scanning allows for quantitative assessment of airway dimensions in vivo [109], which 
might facilitate more accurate diagnosis and treatment, COPD phenotypic dissection [109, 
110, 111], as well as the evaluation of novel therapies [21]. Airways smaller than 2-mm in 
internal diameter are the main sites of airflow obstruction in patients with COPD [97, 112, 
113]; however, they are located from the 4th to the 14th generation of airway branching in the 
lung [97], and thereby are difficult to measure from CT scans due to limited scan resolution 
and high levels of image noise especially when low radiation dose is used. Fortunately, it has 
been demonstrated that CT measurements of larger airways (such as 3rd - 6th generations), 
which can be assessed more precisely from CT, also correlate well with the severity of COPD, 
and may be used as a useful predicator of small airway pathology [101, 96, 100, 114, 103, 
111, 104, 106, 115]. This is because that the same pathophysiologic process may occur at all 
 86 
 
levels of the airway tree [96], although the increased airway wall thickness and the narrowing 
in the larger airways may have no profound functional consequences [115].  
Most research on the quantification of airway dimensions by CT scans to date still 
involves manual editing during the process of airway segmentation, anatomical labeling as 
well as the measurement of airway dimensions [104, 98, 100, 101, 114, 102, 103, 105, 115, 
116]. Various assessment parameters have been proposed in these semi-automated studies, 
including 2D cross sectional measurements such as wall thickness, lumen area and wall area 
percentage, 3D volume based measurements such as wall volume and lumen volume [105], 
branching generation number [105], and intensity based parameter such as peak wall 
attenuation [101]. Wall thickness, lumen area and wall area percentage are the most 
commonly adopted measurements, which were initially acquired from axial CT image slices 
[98, 100, 101, 115] and introduced inaccuracy due to the fact that the airway long axis can be 
oblique to the imaging plane. Recent studies [114, 102, 103, 104, 105, 116] circumvented this 
issue by adopting 3D approaches to first reconstruct airway cross sections orthogonally along 
the airway long axis before performing the measurement. All of the aforementioned semi-
automated approaches require manual intervention, thereby can be time-consuming, prone to 
considerable inter- and intra-observer variability and dependent on the display parameters of 
the CT image (i.e., window settings) [110, 117]. 
A number of fully automated studies [107, 106, 108, 118] have also been conducted to 
assess airway dimensions from CT images, generally including stages of airway 
segmentation, centerline extraction and dimension measurements. Airway dimensions and 
characteristics vary significantly for different regions of the lung and for different generations 
[118], therefore performing reproducible and comparable airway measurements requires the 
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ability to locate the corresponding positions to measure in different scans, which is 
challenging in fully automated studies. Two main schemes have been proposed to find 
corresponding airway locations to perform the airway assessment and enable the inter-patient 
comparison in a cross-sectional study and intra-patient evaluation in a longitudinal study. One 
approach is averaging all detectable airway dimensions at a predefined internal lumen 
perimeter (or equivalently a predefined inner lumen diameter) [106, 115], which has the 
limitation that the measured changes may be due to modifications either in airway lumen, 
airway wall, or both [117], and fails to provide regional (or generation specific) assessment. 
The second approach require automated airway categorizing or labeling [117], so that the 
dimensions can be assessed either by averaging at a special anatomical generation [108, 107] 
or at a specific anatomical bronchus [118].  
The fully automated assessments [107, 108] usually rely on topological generation that 
is defined by the topology of the segmented airway tree: starting from trachea that is of 
topological generation 0, each bronchus of topological generation n, may branch into several 
descendant bronchi of generation n+1. However, all the non-automated studies discussed 
before investigated the anatomical generation that is defined by the anatomical functions of 
airway bronchi as illustrated in Table 4.1, which prevents the direct comparison between most 
of the automated studies and the clinical studies. Moreover, the studies with the ability of 
automated anatomical airway labeling to date have been able to measure airway dimensions 
as far as the 3rd anatomical generation (segmental levels) [118], whereas the semi-automated 
studies can investigate airway up to 6th anatomical generations and demonstrate that the more 
peripheral airway generations usually provide a stronger predictor for airflow obstructions 
[101, 114, 103]. Therefore, a fully automated framework that allows quantification of airway 
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dimensions for specific anatomical bronchi and for averaging over further anatomical 
generations is still needed to facilitate the diagnosis and treatment of COPD.   
The purpose of this study was to develop a fully automated anatomy directed 
framework for the analysis of reproducible and comparable quantitative airway biomarkers 
from low-dose chest CT (LDCT) scans. The airway is first segmented with each bronchus 
labeled with corresponding anatomical name following the nomenclature defined in [119]. 
Then the lumen diameter and wall thickness of each bronchus are measured at each bronchus, 
serving as reproducible and comparable biomarkers that provide valuable information aiding 
the diagnosis and treatment of COPD. 
4.1 Framework for airway anatomical labeling and quantitative biomarker measurements 
The fully automated anatomy directed framework consists of three main stages as 
illustrated in Figure 4.1. First, the airway is segmented with its centerline modeled by a tree 
structure. Second, the lumen diameter and wall thickness are measured at each of the bronchi 
(tree branches). Third, each segmented bronchus is labeled with its corresponding anatomical 
name.  
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Figure 4.1. Flow chart of the presented framework for the quantitative airway image 
biomarker analysis.  
 
The airway segmentation and the tree structure formed by the airway centerline is 
obtained in the first stage of the framework. The airway centerline algorithm was proposed by 
Lee et al. in [67, 120] and consists of three main steps. Frist, the airway is segmented from the 
LDCT scan by 3D region growing within a locally-defined envelope. The airway centerline is 
then obtained by applying 3D thinning to the segmented airway. Finally, a tree structure is 
used to model the airway centerline with individual airway bronchus identified based on the 
analysis of the hierarchy of extracted centerline.  
 The airway dimensions, including the wall thickness and lumen diameter are measured 
in the second stage of the framework by following the approach proposed by Lee et al. in 
[67]. The location of the inner wall and the outer wall is determined for an airway bronchus 
based on the full width at half maximum (FWHM) principle, where the inner wall is defined 
as the boundary between the airway lumen and wall and the outer wall is defined as the 
boundary between the airway wall and lung parenchyma. The lumen diameter and the wall 
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thickness are then derived from the volume and length measurement of each bronchus with 
the assumption that each bronchus can be approximated by a cylinder.   
 
Figure 4.2. The illustration of airway bronchi of anatomical generation 0 – 3 and 
abbreviations used in this study. 
 
Each individual bronchus is identified and assigned with its anatomical name in the 
final stage of the framework. The fully automated anatomical labeling of airway bronchi plays 
an important role in order to enable reproducible and comparable quantitative airway 
biomarkers analysis. It allows the biomarker measurements to be reported for a specific 
bronchus or to be averaged over a specific anatomical generation, leading to direct 
comparison of the biomarker measurements of a patient with that of the healthy subject 
(reference standard), as well as the direct comparison of the biomarker measurements of the 
same subject in longitudinal scans, which may aid the diagnosis and therapy monitoring of an 
extensive variety of airways diseases. In additional, it also allows lobe-based lung heath 
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analysis, as the anatomically labeled airway bronchi potentially formulate the frame of 
location reference in the lung regions.   
  The anatomical labeling of airway bronchi is challenging due to two main reasons. 
First, there is a large variation of the same airway bronchus across individuals in terms of 
length, diameter, running direction, locations, etc., either due to normal individual anatomy 
variations or due to the airway pathology. Second, the airway segmentation errors, such as 
under-segmentation or over-segmentation, and the inaccurate airway tree formulation from 
the airway centerline can also increase the difficulty of the airway labeling.  
 To deal with the anatomy variations and the possible issues resulting from the 
segmentation and skeletonization step, the airway labeling algorithm employs a hierarchical 
labeling order based on anatomy variations and a dynamic airway tree model to allow 
flexibility in the input tree topology. The bronchi with small anatomical variations and 
prominent features are labeled first. The labeled bronchi are then incorporated into the 
knowledge base to aid the labeling of subsequent bronchi. Only one feature, the running 
direction that is relatively unaffected by pathology, is used in the labeling process, except the 
labeling of RLB, which also used the radius of the bronchi, resulting in more robust labeling 
in patient with airway diseases. A dynamic airway tree model is adopted by the algorithm, 
which is constantly adjusted in the labeling process whenever a false bronchus or missing 
bronchus is identified, to improve the robustness of airway labeling with respect to anatomy 
variations and the preceding segmentation issues. 
A novel approach based on an anatomy directed knowledge base was employed to 
label each identified airway bronchus with the corresponding anatomical name. The 
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segmented airway bronchi are labeled in a hierarchical fashion following the topological 
ordered defined in the airway tree obtained in the previous step. The algorithm is designed to 
identify 29 anatomical airway bronchi of anatomical generation 0 – 3, as summarized in Table 
4.1 and illustrated in Figure 4.2. The labeled include 1 zeroth generation bronchus, 2 first 
generation bronchi, 8 second generation bronchi, and 18 third generation bronchi. Bronchi of 
the fourth to ninth generations are labeled with its third-generation ancestor and the 
anatomical generation number. As a consequence, the algorithm is not designed to 
differentiate bronchi of the fourth anatomical generation and above with the same third-
generation ancestor, which is consistent with convention employed in the literature [106, 107, 
108, 118]. The adopted nomenclature follows that defined by Netter in [119]. 
Table 4.1. Airway bronchi of anatomical generation 0 – 3. 
Anatomical 
generation 
Bronchus name Abbreviation Lobe Color  
0 Trachea TRACHEA   
1 Right main bronchus  RMB Right upper lobe  
1 Left main bronchus LMB Light upper lobe  
2 Right upper lobe bronchus RUB Right upper lobe  
2 Right intermediate bronchus RIB Right upper lobe  
2 Middle lobe bronchus  MLB Right middle lobe  
2 Right lower lobe bronchus RLB Right lower lobe  
2 Left upper lobe bronchus LUB Left upper lobe  
2 Left superior division bronchus LSB Left upper lobe  
2 Lingular bronchus  LB Left upper lobe  
2 Left lower lobe bronchus LLB Left lower lobe  
3 Right bronchus 1 RB1 Right upper lobe  
3 Right bronchus 2 RB2 Right upper lobe  
3 Right bronchus 3 RB3 Right upper lobe  
3 Right bronchus 4 RB4 Right middle lobe  
3 Right bronchus 5 RB5 Right middle lobe  
3 Right bronchus 6 RB6 Right lower lobe  
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3 Right bronchus 7 RB7 Right lower lobe  
3 Right bronchus 8 RB8 Right lower lobe  
3 Right bronchus 9 RB9 Right lower lobe  
3 Right bronchus 10 RB10 Right lower lobe  
3 Left bronchus 1+2 LB1+2 Left upper lobe  
3 Left bronchus 3 LB3 Left upper lobe  
3 Left bronchus 4 LB4 Left upper lobe  
3 Left bronchus 5 LB5 Left upper lobe  
3 Left bronchus 6 LB6 Left lower lobe  
3 Left bronchus 7+8 LB7+8 Left lower lobe  
3 Left bronchus 9 LB9 Left lower lobe  
3 Left bronchus 10 LB10 Left lower lobe  
 
 
 
 
Figure 4.3. Illustration of the parent-children bronchi hierarchy, the start and end of a 
bronchus and the running direction.  
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Figure 4.4. Flow chart of the presented algorithm for airway anatomical labeling. 
 
Each segmented airway bronchus is represented by its start coordinates 𝑆, end 
coordinate ?⃑?, which are obtained in the airway skeletonization process, and its radius r that is 
obtained in the airway dimension measurement process as illustrated in Figure 4.3. Except for 
the trachea, each bronchus has a unique parent bronchus. Except for the terminal bronchi, 
each bronchus has at least 2 child bronchi. The parent-child hierarchy can be derived based on 
the overlapping of start coordinates 𝑆 and end coordinate ?⃑?. The absolute running direction of 
a bronchus is defined as a unit vector ?⃑⃑?: 
?⃑⃑? = (dx, dy, dz) = (?⃑? - 𝑆) / | ?⃑? - 𝑆|                                          (4.1) 
The relative running direction of a bronchus is defined as ∆?⃑⃑?: 
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∆?⃑⃑? = (∆dx, ∆dy, ∆dz) = ?⃑⃑? -  ?⃑⃑?p                                             (4.2) 
where ?⃑⃑?p is the absolute running direction of its parent bronchus. 
The labeling process is conducted in a hierarchical fashion defined by the airway tree 
topology as illustrated in Figure 4.4. A processing queue Q is employed to record the child 
bronchi of the most recently labeled bronchus to maintain the labeling order. As a result, all 
candidates in Q have the same parent bronchus with known anatomical label. The candidates 
are then matched to the anatomy-oriented airway model using only two features: the running 
direction and the radius of a bronchus. Given the labeled parent bronchus, the child bronchi 
with small anatomical variations are identified first, and their presence/absence status is taken 
into considerations during labeling of other siblings to resolve confusion.  
The algorithm allows anatomy variations and deals with preceding issues resulting 
from the segmentation and skeletonization step by allowing flexibility in input tree topology. 
Each airway bronchus has a presence/absence status that impacts the anatomy model 
employed to match the subsequent bronchi to be labeled. The algorithm does not require the 
presence of any bronchus (except trachea); once a bronchus is considered absence, then all its 
descendants are considered absence. A false bronchus is detected if it satisfies either of the 
following criteria:  
(i) a zeroth to second generation bronchus with length < Lmin;  
(ii). a candidate in the processing queue Q, which cannot be matched to any of 
children of its labeled parent.  
The false bronchi can be caused by two main reasons: the subject has extra bronchi that are 
not identified in the model; the segmentation errors or the tree skeletonization errors. The 
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false bronchus is ignored in the labeling process. If it satisfies criterion (i), the topological 
generation number of respective descendants are decreased accordingly.  
The flowchart of the algorithm is illustrated in Figure 4.4. The trachea is first labeled 
as it is the most superior bronchus, which can be trivially identified. The children of trachea 
are then labeled as RMB and LMB based on dx. The descendants of RMB are then labeled 
sequentially as RB1 to RB3 as illustrated in Figure 4.5, as RB4 to RB7 as illustrated in Figure 
4.6, and as RB8 to RB10 as illustrated in Figure 4.7. The descendants of LMB are then 
labeled sequentially as LB1 to LB6 as illustrated in Figure 4.8 and as LB7+8 to LB10 as 
illustrated in Figure 4.9. 
 The absence of a bronchus and the different number of segmented child bronchi of a 
bronchus may lead to the variations of the airway model to be matched to in the subsequent 
labeling process. There are five major possible variations of the employed airway model:  
(1). The algorithm allows variation in the topological order of RUB and RB1, as 
illustrated in Figure 4.5. If RUB has two children, then one child bronchus should be 
RB1 and the other should be the extended RUB; On the other hand, if RUB has more 
than two children, then the extended RUB is considered absent. 
(2). The algorithm allows variation in the topological order of MLB, RB6 and RB7, as 
illustrated in Figure 4.6. Among the children of RIB, one must be RLB, and the others 
can be MLB, RB6 or RB7. If the processing queue Q is empty and one of MLB, RB6 
and RB7 is unlabeled, then Q is reinitialized by children of recently labeled RLB, and 
recursively apply the current step to label (extended) RLB, MLB, RB6 and RB7. 
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(3). The algorithm allows variation in the topological order of RLB and RB8, as 
illustrated in Figure 4.7. After the labeling of RB1 to RB7, if RLB has two children, 
then one child bronchus should be RB8 and the other should be the extended RLB. On 
the other hand, if RLB has more than two children, then the extended RLB is 
considered absent. 
(4). The algorithm allows variation in the topological order of LLB, LUB, LB6, LSB, 
and LB, as illustrated in Figure 4.8. If LMB has two children, then they are considered 
to be LUB and LLB. On the other hand, if LMB has more than two children, they can 
be any one of LLB, LUB, LB6, LSB, and LB. The anatomical variation of LLB and 
LB6 are relatively small, hence they are matched first. If one child of LMB is labeled 
as LB, then LUB is considered absent. If no child of LMB is labeled as LB6, then 
LB6, if present, is sought among children of LLB. If LUB is labeled, then LB is 
sought among it children. LSB may be absent depending on the number of candidates 
in the processing queue Q after the labeling of LB. 
(5). The algorithm allows variation in the topological order of LLB and LB7+8, as 
illustrated in Figure 4.9. After the labeling of LB1 to LB6, if LLB has two children, 
then one child bronchus should be LB7+8 and the other should be the extended LLB. 
On the other hand, if LLB has more than two children, then the extended LLB is 
considered absent. 
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Figure 4.5. Flow chart algorithm of labeling RB1 to RB3. 
 
 
Figure 4.6. Flow chart algorithm of labeling RB4 to RB7. Unassigned label is denoted by 
UA. 
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Figure 4.7. Flow chart algorithm of labeling RB8 to RB10. 
 
 
 
Figure 4.8. Flow chart algorithm of labeling LB1 to LB6. Unassigned label is denoted by UA.  
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Figure 4.9. Flow chart algorithm of labeling LB7+8 to LB10. 
 
4.2 Experiments 
Two experiments were conducted to validate the hypothesis that the framework 
generates correct airway segmentation and anatomical labeling, and that repeatable 
measurements of the bronchi were achieved. First, the accuracy of the airway segmentation 
and labeling were evaluated by visual inspection of customized 3D color visualizations of the 
label outcomes for 2727 CT scans. Second, the repeatability of the bronchi dimension 
measurements was evaluated by comparing the measurement results from longitudinally 
separated scans where the assumption was made that any change in actual airway dimensions 
would, in general, be very small. In this case 504 CT scan pairs were compared. 
4.2.1 Label accuracy experiment  
The fully automated quantitative airway biomarker analysis framework was applied to 
a heterogeneous dataset of 2727 LDCT scans. These scans were acquired in several 
institutions with various CT scanner manufactures, scanner models, reconstruction kernels 
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and slice thickness (< =2.0 mm). To evaluate the airway segmentation and anatomical 
labeling performance, 3D visualizations of the airway segmentation and anatomical labeling 
results were generated for each scan. One coronal view and two sagittal views were employed 
for the visual inspections using 3D rendering for all color labeled bronchi and including the 
lung regions for context as shown in Figure 4.10. The trachea (zeroth generation) was colored 
by cyan, two main bronchi (first generation) were colored by purple and the second-
generation bronchi were colored by beige, as listed in Table 1. Each of the 18 segmental level 
(third generation) bronchi, as listed in Table 1, was colored so that nearby segmental bronchi 
do not have the same color. Bronchi of fourth and above generations were colored with the 
same color of their third-generation ancestors.    
The evaluation results were classified into two categories: Good and unacceptable. 
Good results should not contain any visible airway segmentation error (such as over-
segmentation or under-segmentation) or wrong anatomical labeling. Otherwise, the result is 
considered as unacceptable. A case with good segmentation and labeling is shown in Figure 
4.10; A case with unacceptable anatomical label is shown in Figure 4.11, in which LB1+2 and 
LB3 are mislabeled as indicated by arrows.  
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Figure 4.10. 3D visualizations of a good airway segmentation and labeling result. (a) Coronal 
view. (b) Sagittal view (from right to left). (c) Sagittal view (from left to right). The 
segmented lungs are also shown as the reference. The color legend is listed in Table 4.1. 
 
Figure 4.11. 3D visualizations of an unacceptable airway segmentation and labeling result. 
LB1+2 and LB3 are mis-labeled as indicated by the error. (a) Coronal view. (b) Sagittal view 
(from right to left). (c) Sagittal view (from left to right). The segmented lungs are also shown 
as the reference. The color legend is listed in Table 4.1. 
 
4.2.1 Bronchus measurement repeatability experiment  
A subset of the above dataset, consisting of 504 cases, each of which has two 
longitude LDCT scans, is used for the performance evaluation of the airway dimension 
(lumen diameter and wall thickness) measurements. The two longitude LDCT scans of the 
same subject were acquired at two different time-points with the assumption that there is no 
change occurred in airway dimensions within this interval. The performance of the airway 
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measurements is evaluated based on the reproducibility of the measurements, which is 
quantified by the percentage difference defined as following:     
∆t = 100% ⨯ |tt1 – tt2| / (tt1 + tt2)                                              (4.3) 
∆d = 100% ⨯ |dt1 – dt2| / (dt1 + dt2)                                           (4.4) 
Where ∆t and ∆d are the percentage difference for the wall thickness and lumen diameter 
respective; tt1 and tt2 are the wall thickness measurement at time point t1 and t2 respectively; 
dt1 and dt2 are the lumen diameter measurement at time point t1 and t2 respectively.  
 A subset of above, a longitudinal dataset consisting of 86 pairs of CT scans, was used 
to further evaluate the impact of the inspiration level difference and time interval of the scan 
pairs on the reproducibility of the airway dimension (lumen diameter and wall thickness) 
measurements. The two longitude LDCT scans of each subject were acquired with time 
interval < 1 year and at similar inspiration level, which is defined by relative percentage lung 
volume difference < 10%.  
4.3 Results 
89.4% (2439 out of 2727) scans have good airway segmentation and anatomical 
labeling based on visual inspection. 5.0% (135 out of 2727) scans have unacceptable airway 
segmentation and 5.6% (153 out of 2727) scans have good airway segmentation but 
unacceptable anatomical airway labeling. The number of labeled bronchi of each anatomical 
generation (generation 0 to 9) is shown in Table 4.2. The number of each labeled segmental 
level bronchus (3rd anatomical generation) is shown in Table 4.3.  
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Table 4.2. The number of labeled bronchi of each anatomical generation.  
Generation Count Percentage 
0 2470 90.5% 
1 4944 90.6% 
2 17971 82.4% 
3 27051 55.1% 
4 22636  
5 9930  
6 3305  
7 994  
8 353  
9 217  
 
Table 4.3. The number of each labeled segmental level bronchus (3rd anatomical generation). 
Segmental level bronchus Count Percentage 
RB1 1995 73.16% 
RB2 1410 51.71% 
RB3 1636 59.99% 
RB4 1434 52.59% 
RB5 1417 51.96% 
RB6 1776 65.13% 
RB7 1214 44.52% 
RB8 1622 59.48% 
RB9 1147 42.06% 
RB10 1147 42.06% 
LB1+2 1812 66.45% 
LB3 1769 64.87% 
LB4 1068 39.16% 
LB5 1048 38.43% 
LB6 2092 76.71% 
LB7+8 1794 65.79% 
LB9 1335 48.95% 
LB10 1335 48.95% 
 
The evaluation results of the airway dimension measurements for the longitudinal 
datasets are shown in Tables 4.4 – 4.7. For each case, the percentage difference of lumen 
diameter measurement ∆d and the percentage difference of wall thickness ∆t between the two 
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longitudinal scans are computed. The average, min, max and standard deviation of the 
percentage difference are reported. The reproducibility of airway dimension measurements at 
each anatomical generation is summarized in Table 4.4 for the longitudinal dataset of 504 
cases, and in Table 4.6 for the longitudinal dataset of 86 cases. The reproducibility of airway 
dimension measurements at each segmental level bronchus is summarized in Table 4.5 for the 
longitudinal dataset of 504 cases, and in Table 4.7 for the longitudinal dataset of 86 cases.  
Table 4.4. Reproducibility of airway dimension measurements at each anatomical generation 
for the longitudinal dataset of 504 cases. ∆dn is the percentage difference of lumen diameter 
measurement at the n-th anatomical generation. ∆tn is the percentage difference of wall 
thickness measurement at the n-th anatomical generation. The average, min, max and standard 
deviation (SD) of the percentage differences are shown.  
Measurements count Average % Min %  Max % SD 
∆d0 504 3.18 0.00 25.78 3.40 
∆t0 504     
∆d1 504 4.09 0.00 23.27 4.11 
∆t1 504     
∆d2 504 8.22 0.00 33.06 6.32 
∆t2 504 9.15 0.00 44.62 7.77 
∆d3 467 9.40 0.00 56.12 7.61 
∆t3 467 10.57 0.00 57.14 9.16 
∆d4 351 10.44 0.00 78.81 9.93 
∆t4 351 9.39 0.00 43.05 7.47 
∆d5 161 13.91 0.28 89.31 13.83 
∆t5 161 9.61 0.00 54.27 8.90 
∆d6 59 19.07 0.27 78.11 18.87 
∆t6 59 9.74 0.00 31.78 7.15 
∆d7 14 18.85 0.26 59.30 18.29 
∆t7 14 12.25 2.11 30.67 8.39 
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Table 4.5. Reproducibility of airway dimension measurements at each segmental level 
bronchus for the longitudinal dataset of 504 cases. ∆dn is percentage difference of lumen 
diameter measurement at the segmental level bronchus n. ∆tn is percentage difference of wall 
thickness measurement at the segmental level bronchus n. The average, min, max and 
standard deviation (SD) of the percentage differences are shown.  
Segmental 
level 
bronchus 
count Average% Min % Max % SD 
∆dRB1 366 16.63 0.00 86.74 16.27 
∆tRB1 366 15.56 0.00 100.85 14.41 
∆dRB2 232 15.50 0.00 63.99 13.03 
∆tRB2 232 11.13 0.00 46.30 8.60 
∆dRB3 283 16.04 0.17 63.60 15.50 
∆tRB3 283 17.91 0.00 99.82 18.11 
∆dRB4 259 16.35 0.00 64.97 13.61 
∆tRB4 259 13.48 0.00 94.77 15.49 
∆dRB5 256 15.38 0.00 80.85 14.61 
∆tRB5 256 15.76 0.00 85.95 15.81 
∆dRB6 322 17.64 0.00 88.89 15.95 
∆tRB6 322 13.35 0.00 80.69 12.08 
∆dRB7 214 14.02 0.00 60.30 11.83 
∆tRB7 214 12.76 0.00 68.75 12.02 
∆dRB8 239 16.74 0.00 79.45 15.75 
∆tRB8 239 11.78 0.00 79.03 11.40 
∆dRB9 133 20.73 0.00 95.22 19.53 
∆tRB9 133 14.57 0.63 59.69 12.01 
∆dRB10 133 21.98 0.00 76.01 18.65 
∆tRB10 133 12.23 0.00 79.25 13.12 
∆dLB1+2 300 16.81 0.18 80.73 15.36 
∆tLB1+2 300 12.58 0.00 76.56 12.46 
∆dLB3 299 17.98 0.00 76.78 16.68 
∆tLB3 299 12.52 0.00 85.71 13.80 
∆dLB4 147 16.88 0.00 72.83 14.85 
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∆tLB4 147 11.71 0.51 44.95 8.98 
∆dLB5 142 13.56 0.00 67.79 13.18 
∆tLB5 142 12.39 0.55 72.19 11.65 
∆dLB6 397 15.25 0.00 71.79 13.74 
∆tLB6 397 13.95 0.00 67.69 13.34 
∆dLB7+8 316 19.58 0.25 72.76 15.55 
∆tLB7+8 316 15.65 0.50 78.30 14.56 
∆dLB9 205 19.35 0.00 88.03 17.62 
∆tLB9 205 18.31 0.00 96.88 17.94 
∆dLB10 205 18.00 0.00 86.05 18.03 
∆tLB10 205 10.94 0.00 73.09 9.70 
 
Table 4.6. Reproducibility of airway dimension measurements at each anatomical generation 
for the longitudinal dataset of 86 cases. ∆dn is percentage difference of lumen diameter 
measurement at the n-th anatomical generation. ∆tn is percentage difference of wall thickness 
measurement at the n-th anatomical generation. The average, min, max and standard deviation 
(SD) of the percentage differences are shown.  
Measurements count Average % Min % Max % SD 
∆d0 86 2.07 0.00 11.07 1.84 
∆t0 86     
∆d1 86 2.50 0.00 20.13 2.63 
∆t1 86     
∆d2 86 6.99 0.26 28.38 5.38 
∆t2 86 8.66 0.00 44.62 8.38 
∆d3 81 8.89 0.20 56.12 9.04 
∆t3 81 9.78 0.00 47.84 8.96 
∆d4 62 9.28 0.00 68.79 10.46 
∆t4 62 8.74 0.55 36.95 7.94 
∆d5 38 13.97 0.79 89.31 15.19 
∆t5 38 9.47 0.00 54.27 12.09 
∆d6 12 21.86 2.21 78.11 24.69 
∆t6 12 7.05 0.00 25.22 6.88 
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∆d7 2 7.54 4.67 10.40 2.87 
∆t7 2 14.05 7.85 20.25 6.20 
 
Table 4.7. Reproducibility of airway dimension measurements at each segmental level 
bronchus for the longitudinal dataset of 86 cases. ∆dn is percentage difference of lumen 
diameter measurement at the segmental level bronchus n. ∆tn is percentage difference of wall 
thickness measurement at the segmental level bronchus n. The average, min, max and 
standard deviation (SD) of the percentage differences are shown.  
Segmental 
level 
bronchus 
count Average% Min % Max % SD 
∆dRB1 65 14.79 0.00 70.89 16.81 
∆tRB1 65 12.14 0.00 50.98 10.71 
∆dRB2 43 11.97 0.27 54.02 10.61 
∆tRB2 43 11.85 0.61 46.30 10.55 
∆dRB3 54 17.84 0.27 58.20 15.80 
∆tRB3 54 21.28 0.49 90.55 22.47 
∆dRB4 50 17.56 0.26 48.65 12.79 
∆tRB4 50 13.17 0.00 71.22 15.93 
∆dRB5 50 12.53 0.00 52.35 11.60 
∆tRB5 50 15.74 0.00 85.95 18.03 
∆dRB6 63 14.60 0.19 55.11 11.22 
∆tRB6 63 12.21 0.00 38.95 9.67 
∆dRB7 47 13.72 0.00 55.79 13.27 
∆tRB7 47 10.63 0.00 53.33 11.42 
∆dRB8 45 11.86 0.11 46.48 9.95 
∆tRB8 45 9.79 0.00 39.13 8.61 
∆dRB9 37 15.88 1.09 54.31 14.39 
∆tRB9 37 13.00 0.63 59.69 10.98 
∆dRB10 37 20.22 0.56 68.65 20.93 
∆tRB10 37 10.32 0.00 53.41 11.68 
∆dLB1+2 55 16.81 0.71 64.00 16.39 
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∆tLB1+2 55 12.31 0.00 58.14 12.91 
∆dLB3 55 16.85 0.13 68.03 16.83 
∆tLB3 55 13.97 0.58 75.35 17.60 
∆dLB4 24 21.51 0.29 72.83 20.59 
∆tLB4 24 11.52 1.99 35.22 9.54 
∆dLB5 21 15.07 0.68 57.72 16.20 
∆tLB5 21 14.79 0.69 61.89 14.61 
∆dLB6 74 14.84 0.00 61.00 13.36 
∆tLB6 74 13.15 0.00 57.56 13.51 
∆dLB7+8 63 15.96 0.72 54.08 14.03 
∆tLB7+8 63 14.07 0.50 72.27 14.10 
∆dLB9 48 20.03 0.28 88.03 19.31 
∆tLB9 48 14.26 0.66 47.89 12.00 
∆dLB10 48 16.91 0.19 56.67 16.27 
∆tLB10 48 8.74 0.00 38.40 7.94 
 
4.4 Discussion 
 The number of labeled bronchi is summarized in Tables 4.2 and 4.3. The percentage of 
the labeled bronchi decreases as the anatomical generation increases, which can be explained 
by the fact that the more peripheral airway bronchus, often with smaller lumen diameter, is 
more difficult to segment or measure accurately given the limited scan resolution. There is a 
large variation in the percentage of the labeled bronchi at the segmental level (3rd anatomical 
generation), as shown in Table 4.3. More than 80% of RB1 and LB6 can be obtained; while 
only approximately 40% of RB9, RB10, LB4 and LB5 can be obtained. This can also be 
explained by the fact that bronchi with smaller lumen diameter are more challenging to 
segment or measure accurately as different segmental level bronchi are located at different 
lung regions and have different lumen diameters. For example, RB9 and RB10 are considered 
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to be more challenging to obtain, as they usually have smaller lumen diameter compared to 
RB1.  
 The reproducibility of airway dimension measurements for the longitudinal datasets is 
summarized in Tables 4.4-4.7. A percentage difference of less than 10% was obtained for 
most segmental level (3rd generation) bronchi as indicated in Tables 4.4 and 4.6. Whether this 
reproducibility of measurement is sufficient to be clinically useful? The answer depends on 
the impact of diseases of interest on the airway dimensions, which is still a subject of ongoing 
research.      
The measurement reproducibility (as measured by the percentage difference in 
longitudinal scans) decreases as the anatomical generation increases, as shown in Tables 4.4 
and 4.6, which can be explained by the fact that more peripheral bronchi (with smaller lumen 
diameter) are more difficult to measure accurately given the limited scan resolution. In 
addition, the more peripheral airway dimensions are more likely to be affected by the airway 
diseases [101, 114, 103] and by the inspiration levels [118], leading to a larger percentage 
difference in longitudinal scans. The measurement reproducibility varies across the segmental 
level bronchi and the wall thickness in general has better reproducibility compared to lumen 
diameter, as shown in Tables 4.5 and 4.7. For the dataset of 504 cases as shown in Table 4.5, 
the most robust wall thickness measurement is obtained at RB2 with a percentage difference 
of 11.13% and the most robust lumen diameter measurement is obtained at LB5 with 
percentage difference of 13.56%. For the dataset of 86 cases as shown in Table 4.7, the most 
robust wall thickness measurement is obtained at RB8 with percentage difference of 9.79% 
and the most robust lumen diameter measurement is obtained at RB8 with percentage 
difference of 11.86%. The differences in the measurement robustness across the segmental 
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level bronchi suggest that certain anatomical bronchi may be more suitable to be used in the 
study of the airway dimensions.  
 The measurement reproducibility of the 86-case dataset with more strictly controlled 
inspiration level difference and scan time interval, is better than that of the 504-case dataset, 
as shown in Tables 4.4-4.7. This can be explained by the fact that in the reproducibility study 
using longitudinal datasets, the validity of the assumption that there is no change occurred in 
airway dimensions within the time interval between the two longitudinal scans is influenced 
by two main factors: the length of the time interval and the inspiration level difference. If the 
time interval between the two longitudinal scans is long, airway diseases are more likely to 
develop, which may lead to variations in the airway dimensions. The inspiration level also has 
a huge impact on the airway dimensions as pointed out by Petersen et al. in [118]: Airway 
lumen diameter increases and wall thickness decreases with inspiration. The effect of 
inspiration is greater in higher-generation airways. The experiment results of the measurement 
reproducibility in the two longitudinal datasets suggest that for the future work, the inspiration 
level difference and scan time interval of the longitudinal scan pairs must be carefully 
controlled to achieve precise airway measurements and meaningful longitudinal comparison.  
4.5 Conclusion 
A fully automated anatomy directed framework is presented for the analysis of 
reproducible quantitative airway biomarkers from LDCT scans acquired from the annual lung 
cancer screening. The airway is first segmented with each bronchus labeled with 
corresponding anatomical name. The lumen diameter and wall thickness of each bronchus are 
then measured at each bronchus, serving as reproducible biomarkers that provide valuable 
information aiding the diagnosis and treatment of COPD. The framework was evaluated with 
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a dataset of 2727 LDCT scans and good airway segmentation and labeling were obtained in 
89.4% of scans based on visual inspection. The airway biomarker measurement is evaluated 
with a longitudinal dataset of 504 cases and demonstrates good reproducibility in both lumen 
diameter measurement and wall thickness measurement.  
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CHAPTER 5 
PULMONARY NODULE CLASSIFICATION USING 3D CONVOLUTIONAL NEURAL 
NETWORK 
 
Annual lung cancer screening with low-dose chest CT has recently been approved in the 
United States for the early detection and treatment of lung cancer for people at high risk, with 
approximately 8.7 million Americans eligible for the screening [121]. The costly follow-up 
procedures provide motivation for the development of systems for establishing the 
malignancy status of pulmonary nodules from low-dose chest CT images. The purpose of this 
study is to determine the benefits of applying a novel machine learning approach, 3D 
convolution neural network (CNN), to the task of pulmonary nodule classification from low-
dose chest CT scans obtained from lung cancer screening, through the performance 
comparison with traditional machine learning approaches. In addition, the classifier 
ensembles of the different combinations of the 3D CNN and traditional machine learning 
classifiers based on handcrafted 3D image features are also explored to study the key to the 
success of the ensembles. 
A typical automated system for lung cancer diagnosis generally consists of two stages: 
pulmonary nodule detection and pulmonary nodule malignancy classification. This study 
focuses on the latter stage, namely the discrimination between benign pulmonary nodules and 
malignant pulmonary nodules given the nodule location and size from the volumetric low-
dose chest CT scans acquired during the lung cancer screening.      
 114 
 
 The conventional automated approaches to the discrimination between benign 
pulmonary nodules and lung cancer generally consist of four major stages [122]: 1) Nodule 
segmentation; 2) Image feature extraction from the segmented nodules; 3) Feature selection 
based on the discriminative power of the features; and 4) Machine learning classifier training 
given the selected features. A wide range of image features, such as gray-level distribution, 
size, morphology as well as texture description, and various types of machine learning 
models, including linear discriminant analysis [123, 124], support vector machines (SVM) 
[125, 126], massive training artificial neural network [127], random forest [122], and distance 
weighted nearest neighbor [126, 128], have been explored in the literature [122, 129, 124, 
125, 126, 128] to address the problem of pulmonary nodule classification. The fast volume 
growth rate of a nodule [23] serves as a reliable indicator for malignancy, however it usually 
requires more accurate image segmentation for the nodule volume measurement and at least 
two CT scans, which prolongs diagnosis and exposes the patient to possibly unnecessary 
radiation exposure [125, 126, 128].  
 The astounding revival of convolutional neural networks (CNNs) [130, 131] since 
2012, owing to the availability of large-scale annotated image datasets [132] and affordable 
parallel computing resources [133], has led to remarkable advances [131, 134, 135, 136] in 
several computer vision applications of natural images and the birth of deep learning, a new 
area of machine learning research. The application of deep learning techniques to various 
automated medical imaging analysis problems has also been explored in a large number of 
published work [137], which can be summarized in the following three primary categories 
[138]. First, off-the-shelf deep features can be extracted directly from pre-trained deep 
learning networks and then fed into traditional machine learning models, such as SVM and 
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random forest, to address the detection or classification problems [139, 140, 141, 142]. 
Although the performance of using only off-the-shelf deep features is normally inferior to the 
traditional state-of-the-art features acquired by careful feature engineering [142, 139, 140, 
141], the ensemble of both can result in substantial improvement [139, 140, 141]. Second, 
fine-tuning deep learning models pre-trained on irrelevant and typically non-medical images, 
has been demonstrated to outperform the state-of-the-art traditional approaches [143, 138]. 
Third, effective deep learning models can also be trained from scratch. It can be used either 
from-to-end [133, 138, 144, 145, 146, 147, 148, 149, 150, 151] [152] or as a feature extractor 
only [153, 145, 154, 155], which requires succeeding traditional approaches such as the 
conventional classifier for classification applications or the deformable shape model for 
segmentation applications.    
 Pulmonary nodule detection and classification from CT scans is a 3D problem, 
whereas most of the published work on deep learning still adopts a 2D approach [133, 156], 
since the CNNs were originally proposed for 2D natural images with RGB color channels. In 
order to utilize the established network architectures and pre-trained network weights, the 
most common solution is to map each 3D volumetric CT scan into a 3-channel 2D image by 
assigning 3 orthogonal planes, which can be axial, coronal and sagittal slices [139, 142, 143] 
or even planes with random orientations [133, 145, 144], to 3 different channels. It effectively 
reduces the network complexity, in terms of the number of trainable weights and the required 
memory for the computation as well as data storage, and the amount of the training data 
needed to avoid overfitting; however, the concern of the loss of 3D information still exists 
[156]. A number of recent publications have started to employ 3D CNNs in various types of 
medical imaging applications, including pulmonary nodule [147] and cerebral microbleeds 
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[148] detection, prostate finding [149] and breast mass [150] classification, and different 
types of anatomy segmentation [151, 152, 157, 154, 155]. 3D CNN has been shown to 
achieve significant performance enhancement attributed to the consideration of contextual 
information along the 3rd spatial dimension, compared to the corresponding 2D CNN, by 
Cicek et al. [151] for the segmentation of xenopus kidney, by Dou et al. [148] for the 
detection of cerebral microbleeds, and by Li et al. [150] for the classification of breast masses. 
For the application of pulmonary nodule classification, no published work has been found on 
the employment of a 3D CNN, which may potentially provide benefits due to the 
consideration of the full 3D data [125]. In the CNN proposed by Shen et al [146, 145], 
although 3D image patches around the nodules are directly fed into the input layer, the 
network is still not completely 3D, because no convolution operation or pooling operation is 
performed along the 3rd spatial dimension, which is treated as the channel dimension.  
The matching of size distribution for malignant and benign nodules in the validation 
set is necessary for a meaningful assessment of automated systems for pulmonary nodule 
classification as first noted in 2007 [128] and also in [122, 126]. Datasets with benign nodules 
dominating the small size range and malignant nodules dominating the large size range are 
very common in the published studies [158, 123, 124, 127, 159], since the nodule malignancy 
is highly correlated to nodule size. However, algorithm performance evaluated on such a 
dataset can be misleading and overly optimistic [122, 126, 128], because a simple size 
classifier that is based on nodule size thresholding only, may achieve promising performance, 
due to correctly classifying very large and very small nodules. However, such a classifier 
would not be effective to classify the malignancy status of nodules of intermediate sizes 
which are the most frequent in lung cancer screening and of most interest to clinical practice. 
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A balanced class distribution (i.e., approximately equal number of benign and 
malignant nodules in our case) is another favorable property of the validation set for a 
classification problem evaluated using receiver operating characteristic (ROC) curves. A large 
skew in class distribution in the validation set can lead to overly optimistic view of an 
algorithm’s performance based on ROC curves [160]. Therefore, it can be unfair to directly 
compare the ROC curves of the algorithms evaluated on the datasets with different amount of 
skewness.   
 The reported performance of automated nodule classification systems spans a very 
large range [122, 123, 124, 125, 23, 127, 128, 143, 153, 145] [146], with area under the ROC 
curve (AUC) ranging from 0.50 [122] to 0.93 [146]. However, the performance between 
studies is generally not comparable due to two primary reasons [122]. First, different datasets 
were employed for the evaluation of each study; therefore, direct comparison is meaningless 
[161]. And especially as discussed above, a biased validation set may lead to unfair 
assessment of its performance [138]. Moreover, studies [123, 124, 126, 127, 128] that focus 
on pulmonary nodule classification from low-dose CT images acquired during lung cancer 
screening are considered more challenging [126, 128] compared to other studies [122, 125, 
143, 153, 145, 146] that include standard-dose CT images acquired during clinical practice, 
due to the small size of the present nodules and the high level of image noise [23, 127]. The 
current scan protocol in lung cancer screening (fixed CT scan resolution of 512 pixels across 
lungs) limits the number of pixels available for analysis especially for nodules of small size, 
which are the most clinically relevant for early detection of lung cancer. Second, different 
evaluation schemes were used. For instance, the malignancy status is confirmed by biopsy 
outcome in some studies [122, 123, 124, 126, 127, 128, 153], whereas in other studies [125, 
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143, 145, 146], the malignancy status is established purely based on malignancy ratings of 
radiologists after reviewing the CT scans, where inter-observer differences can be significant 
[122, 143]. In addition, the cross-validation strategy, such as leave-one-out compared to 5-
fold-cross-validation, may have a significant impact on the resulting performance [138].    
In this study, we have applied a 3D CNN trained from scratch to the classification of 
pulmonary nodule malignancy using a class-balanced and size-matched low-dose chest CT 
dataset, where the malignancy status is pathologically confirmed. Since the exact same 
training and validation dataset as well as the evaluation scheme were employed in a previous 
study based on handcrafted features and traditional machine learning models by Reeves et al 
[126], a direct performance comparison between the 3D CNN and conventional approaches to 
the pulmonary nodule classification is possible. The ensemble models of the different 
combinations of the 3D CNN and traditional machine learning models were also explored. 
Moreover, the performance comparison between 3D CNN and 2D CNN architectures were 
investigated. Our hypothesis is that the CNN can learn the 3D image features automatically 
and achieve at least the same classification performance compared to the conventional 
approaches that are based on handcrafted image features and traditional machine learning 
classifiers. In addition, since the features learned by CNN should be complementary to the 
handcrafted features, the ensembles should achieve further performance improvement. 
Finally, performance enhancement can be obtained by using 3D CNN compared to using 2D 
CNN due to the consideration of the of contextual information along the 3rd spatial 
dimension. 
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5.1 3D Convolutional neural network architectures  
A CNN [130] is a specialized type of feedforward neural network (or multilayer 
perceptrons), which incorporates convolution operations in at least one of its computational 
layers and is typically applied to input data with grid-like topology, such as image data [162]. 
A feedforward neural network is made up by a number of concatenated computational layers, 
where the computational outcome, namely feature map, of each layer is simply a 
mathematical mapping of the output of the previous layer. The composition of all 
computational layers contained in the network together defines a mapping Y = f (X; θ) from 
the input tensor X (3D image matrix in our study here) to the output tensor Y (1D class vector 
in our study here), where θ is a set of mapping parameters (or weights) to be learned during 
the training process [162]. 
 A Conv layer maps an input tensor X to an output tensor Y by the convolution of 
kernel tensor K and the input X across each spatial axis. Let Yc, x, y, z denote value of the c-th 
channel of the output 4D tensor Y (namely 4D feature map) at spatial location (x, y, z), then 
the computation defined by a 3D Conv layer is given in equation (5.1): 
𝑌𝑐,𝑥,𝑦,𝑧 = 𝐶𝑜𝑛𝑣(𝑋, 𝐾) + 𝐵𝑐 =  ∑ ∑  𝑋𝑐′,   𝑥𝑠+ 𝑖,   𝑦𝑠+𝑗,   𝑥𝑠+ 𝑘   𝐾𝑐,𝑐′,𝑖,𝑗,𝑘 𝑖,𝑗,𝑘  𝑐′  + 𝐵𝑐          (5.1) 
Where s is the stride for convolution; 𝑋 𝑐′,𝑥,𝑦,𝑧 is the value of c’-th channel of the input 4D 
tensor X (usually feature map output by previous layer if it is not the input data layer) at 
spatial location (x, y, z); 𝐵𝑐 is the bias for the c-th output channel; and 𝐾 c,𝑐′,𝑖,𝑗,𝑘 is the (i, j, k)-
th element of the kernel, corresponding to the connection strength between a unit in the c’-th 
input channel and a unit in the c-th output channel with spatial offset of (i, j, k) between the 
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output unit and the input unit [162]. The summation iterates over all input channels and the 
3D spatial dimensions of the kernel. 
A FC layer defines a mapping that is simply an inner product of the input vector X and 
weight matrix W with the addition of the bias vector B. Thus, the output vector Y can be 
computed by equation (5.2): 
Y = W X  + B                                                     (5.2) 
The ReLU layer is employed to incorporate non-linearity into the network and thus to 
increase the capacity of the overall model. It is an element-wise operation defined for each 
input unit x as shown in equation (5.3): 
y = max (0, x)                                                  (5.3) 
 The Softmax layer and cross entropy loss layer are generally located at the end of the 
network and together serve as the output layer. The Softmax layer is used for converting the 
input N-dimensional (i.e., N classes) prediction score vector Y into an N-dimensional 
prediction probability vector ranging from 0 to 1. If we let Pc denote the output probability for 
class c, and Yc denote the input prediction score for class c, then the Softmax function is 
defined in equation (5.4): 
𝑃𝑐  =  Softmax(Y)c  = 
𝑒𝑌𝑐
∑ 𝑒𝑌𝑑𝑁𝑑=1
                                 (5.4)  
The cross entropy loss layer takes the ground truth class label c’ and prediction 
probability for class c’ to compute the cross entropy loss L as shown in equation (5.5): 
       L = - log 𝑃𝑐′                                                    (5.5) 
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Figure 5.1 Cropped 3D CT volume used as the input to the CNN. (a). 16x16x16 re-sampled 
isotropic CT volume centered at a nodule. (b-f) 5 axial slices at the corresponding axial level. 
 
5.1.1 Nodule image pre-processing 
Each nodule CT volume is cropped into a real space cube around the nodule center 
with a margin of 20% of the nodule radius as shown in Figure 5.1, to include approximately 
the same volume for background context as the nodule itself. The nodule location (center) and 
size (radius) are determined from automated nodule segmentation [126, 23]. The cropped 3D 
image region is then resampled using tricubic interpolation to an isotropic fixed size 3D 
image.  
For these CT images, the x and y dimensions have the same resolution and the z 
dimension (slice spacing) usually has a lower resolution. As detailed in section 5.2.1, the 
pixels in the data set, in general, varied in a size range from 0.5 to 0.85 mm in the x and y 
dimensions and from 1.0 to 2.5 mm in the z dimension. Two different resampled image sizes 
were independently explored for the CNN network: 16x16x 16 and 32x32x32. For the 
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32x32x32 image size, oversampling occurred in all three dimensions since none of the 
cropped image regions had any dimension with more than 32 pixels in the original CT scan. 
For the 16x16x16 image size, 27.6% of the cropped image regions (corresponding to the 
largest nodules) had an xy dimension greater than 16 pixels; no cases had more than 16 pixels 
in the z dimension (the largest cropped region xy dimension was 31 pixels (median = 13) and 
the largest z dimension was 15 pixels). Therefore, for these 27.6% cases there was some 
amount of undersampling (possible information loss), although oversampling always occurred 
in the z dimension. 
The image pixel values are first converted to the Hounsfield unit (HU) scale, then 
clipped between [-800, 200] HU considering the common image intensity distribution of 
pulmonary nodules, and scaled by 1/200. The resulting image intensity distribution is in the 
range [-4, 1] with most of the nodule pixels approximately zero-centered in the range [-1, 1]. 
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Figure 5.2. The presented CNN1 architecture. The spatial dimension and the number of 
channels of the feature map in each hidden layer are denoted on the bottom. The dimension 
and the number of kernels as well as the size of padding and stride used in each Conv layer 
and the number of output neurons in each FC layer are denoted on the top. 
 
5.1.2 3D CNN architectures 
 Three 3D CNN architectures, CNN1, CNN2 and CNN3, are considered in this study. 
CNN1 takes an input image of size 16x16x16, and consists of two 3D convolutional (Conv) 
layers followed by two fully connected (FC) layers with one Rectified Linear Units (ReLU) 
layer inserted between each pair of adjacent hidden layers, as illustrated in Figure 5.2. The 
spatial dimension and the number of channels of the feature map in each hidden layer are 
denoted on the bottom of the figure. The dimension and the number of kernels as well as the 
size of padding and stride used in each Conv layer and the number of output neurons in each 
FC layer are denoted on the top of the figure. CNN2 and CNN3 employs deeper (one 
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additional convolutional layer) and wider network compared to CNN1; in addition, CNN2 
takes larger input images of size 32x32x32 as detailed in Table 5.1.  
Table 5.1. Description of CNN architectures and overall performance. The kernel size, 
padding size, and stride size are the same for all spatial dimensions, thus only one number is 
specified in the table, e.g., kernel size of 3 indicates 3x3x3 for 3D network. A Conv layer with 
n kernels is denoted as Conv-n, with default kernel size of 3, padding of 1, and stride of 1. A 
FC layer with n output neurons is denoted as FC-n. A ReLU non-linearity layer is inserted 
after each Conv layer and the 1st FC. All parameter values other than the default are specified 
explicitly below. The same output layer Softmax + Cross entropy are used for all models and 
not shown below. 
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The presented CNN architectures, including the input volume size, types of layers, 
network depth, kernel size, the number of kernels and neurons, etc., was based on the 
architectures proposed in several recent studies [133, 138, 146, 147, 148, 154], taking into 
consideration of the size of the input image volume and the training set to avoid over-fitting. 
It is infeasible to employ many layers of feature abstractions as discussed by Dou et. al. in 
[148], since our task is a binary classification problem with relatively small size of input 
16x16x16 or 32x32x32. Moreover, less complicated CNN architectures are better suited due 
to the small scale of training dataset. In fact, in several recent studies [133, 146, 147, 148, 
154] using CNN trained from scratch for discrimination task in medical imaging processing, 
no more than 3 convolutional layers are used and the maximal number of convolutional 
kernels is 64. 
5.2 Ensembles of CNN and traditional models 
Classifier ensembles have been shown to consistently outperform a single best 
classifier [139, 163, 164], assuming sufficient diversity among the included classifiers. The 
presented CNN model can be considered complementary to the conventional machine 
learning models [139, 143] because of two main reasons. First, traditional models are built 
upon handcrafted features that were designed empirically with respect to gray-level 
distribution, size, morphology as well as texture pattern; whereas the features employed by 
the CNN are learned by the network automatically. Second, the design of the two types of 
classifiers are also different, namely they target optimizing different types of loss functions 
with CNN potentially providing significantly increased model capacity. Therefore, ensembles 
of CNN and traditional models have the potential to give rise to remarkable performance 
enhancement. 
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Figure 5.3. The construction of the ensemble models. Models of 4 different categories are 
differentiated by colors: size-universal single models ( ), size-binned single models ( ), 
size-universal ensemble models ( ), and size-binned ensemble ( ) models. For the inputs 
to the 2nd-stage classifiers, the dashed line indicates the respective input may or may not be 
used.  
 
Two types of traditional nodule classification models, size-universal model and size-
binned model, presented by Reeves et al in [126] are used in combination with CNN model to 
construct ensemble models in this paper. The size-universal model consists of one classifier 
that is trained in the class-balanced and size-matched dataset and is applicable to classify 
nodules of any size. The size-binned model consists of several classifiers, each of which is 
trained with and applicable to nodules of a specific size range. Both 3-bin model (including 
B6 for diameter of (5, 7) mm, B8 for diameter of (7, 9) mm and B12 for diameter of (9,14) 
mm) and 2-bin model (including B6 for diameter in (5, 7) mm and B8+12 for diameter in (7, 
14) mm) were presented in [126].  
The same set of handcrafted image features is used in the aforementioned two types of 
traditional nodule classification models. The feature set consists of 46 3D image descriptors in 
terms of morphology, density, curvature and margin gradient. The details on the definition 
and generation of the image features are described by Reeves et al in [126]. Four traditional 
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classifiers, including distance-weighted nearest neighbor (NN) [165], logistic regression 
(LOG) [166], support vector machine with polynomial function kernel (SVMp) and support 
vector machine with radial basis function kernel (SVMr) [167], were explored for each of the 
two models. 
The CNN model and the traditional models are combined into ensemble models by a 
second-stage classifier [139, 142] as illustrated in Figure 5.3. Before the combination, the 
classification scores predicted by each single model are first standardized to zero-mean and 
unit-variance. A second-stage classifier then takes the standardized scores as input features 
and generates classification scores to serve as the final prediction of the ensemble model.  
5.3 Experiments 
For the verification of the proposed hypothesis, three primary experiments were 
conducted. First, the three 3D CNN models and six 2D CNN models were trained and 
evaluated using 5-fold cross validation. Second, the 3D CNN1 model was then compared to 
the 4 size-universal traditional models presented by Reeves et al [126]. Since exactly the same 
training-validation-testing partition and evaluation scheme were employed, the effectiveness 
and strength of the 3D CNN model can be demonstrated. Third, the classifier ensembles 
constructed with different combinations of single classifiers were compared to explore the key 
to performance enhancement in classifier ensembles.    
5.3.1 Dataset description 
The dataset was constructed by combining CT scans from two large lung cancer 
screening studies, the National Lung Cancer Screening Trial (NLST) [8] and Early Lung 
Cancer Action Program (ELCAP) [7]. Only one instance of a nodule was used per subject. 
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The status of malignant nodules was confirmed by either biopsy or histology of resected 
tissue, while the status of benign nodules was established based on a negative outcome of the 
biopsy or histology of resected tissue or by 2 years of no clinical change determined by a 
board-certified radiologist.  
The dataset is class-balanced with equal size distribution for benign and malignant 
nodules. The same number of benign and malignant nodules, namely 163 benign and 
malignant nodules, were included. The size distribution for the benign nodules is the same as 
that for the malignant nodules: 44.79% nodules with a diameter between 5.0 and 7.0mm, 
28.22% nodules with a diameter between 7.0 and 9.0mm and 26.99% nodules with a diameter 
between 9.0 and 14.0mm. Only solid nodules and solid component of part-solid nodules are 
considered as in the study by Reeves et. al [126]. A summary of distribution of the nodule 
sizes and classes is given in Table 5.2. 
The CT scans were obtained using a wide range of scanners, including Siemens, GE 
Medical Systems, Philips and Toshiba scanners, and image resolutions, where 95.4% CT 
scans have in-plane resolution in the range of [0.5, 1.0] mm and 98.2% CT scans have vertical 
resolution in the range of [1.0, 2.5] mm. More details about the process of dataset construction 
are described in [126]. 
Table 5.2. The distribution of nodule sizes and classes. 
 Number of 
nodules 
Min size 
(diameter in 
mm) 
Max size 
(diameter in 
mm) 
Average size 
(diameter in 
mm) 
Median size 
(diameter in 
mm) 
Malignant 163 5.01 14.00 8.05 7.21 
Benign 163 5.02 13.91 8.01 7.27 
All 326 5.01 14.00 8.03 7.22 
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5.3.2 Training and Testing 
The dataset is randomly divided into 5 approximately equal sized folds with balanced 
size and class distribution. The 5-fold partition is the same with that used by Reeves et. al in 
[126] to ensure fair comparison. During the 5-fold cross validation, each fold is iteratively 
tested while the other 4 folds are further split to be used for the training set (85%) and 
validation set (15%). The performance of the 5 testing folds is averaged and considered as the 
overall performance of the testing model. 
 
Figure 5.4. Data augmentation by rotation. (a) 4 orientations on the axial (x-y) plane. (b) 2 
orientations along the vertical (z) direction.  
 
 Data augmentation is employed during the training of CNN models to reduce 
overfitting. Each nodule volume is rotated into 8 different orientations, including 4 rotations 
by 90° about the z axis and 2 rotations by 180° about the x axis (in this case, it can also be 
viewed as rotation about the y axis) as indicated in Figure 5.4, which results in an augmented 
dataset of 326 x 8 = 2608 nodule volumes. Many additional augmentations through other 
angle rotations or mirroring are possible. Rotations of 90° about the x or y axes were avoided 
due to the difference in resolution between the x, y and z dimensions; x and y resolutions of 
all scans are < 1.0 mm while z resolution of all scans are ⩾ 1.0 mm and 60% scans are ⩾ 2.0 
mm. The augmented data is not used during the testing. 
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The weights in Conv layers are initialized using random Gaussian distributions with 
standard deviation of 0.01, and the weights in FC layers are initialized according to the Xavier 
algorithm as suggested by Glorot et al in [168]. In each round of the 5-fold cross validation, 
the network is trained up to 6000 epochs with the mini-batch size of 16 nodule image 
volumes. Early termination is adopted to reduce overfitting based on the performance tested 
in the validation set.  
Stochastic gradient descent with moment of 0.9 is used for the training. To avoid 
overfitting, L2 regularization and dropout (only for the 1st FC layer) with dropout ratio of 0.5 
are incorporated. The initial learning rate η0 and weight decay C parameter are hyper-
parameters tuned by random search in the range η0  ∈ [1e-5, 1e-2] and C ∈ [1e-4, 1e-2] based 
on the performance tested in the validation set. The learning rate is decreased according to the 
strategy defined in equation (5.6): 
η(n) =  
η0
(1+ 1𝑒−4 𝑛)0.75
                                                                (5.6) 
where η(n) is the learning rate at training iteration of n. 
The CNNs were implemented and evaluated using Caffe framework [169] on 5 
Intel(R) CPUs 2.6GHZ with CentOS Linux OS and 2 NVIDIA Tesla K40c GPUs. 
5.3.3 Ensembles 
As summarized in Table 5.3 and Figure 5.3, 18 ensemble models are constructed using 
different combinations of 7 single models (M1 – M7). In order to demonstrate the benefits 
resulting from the incorporation of 3D CNN model into the ensembles of other traditional 
models, the ensemble models are constructed in pairs, one with 3D CNN and the other 
without 3D CNN, as in M8 vs. M9, M10 vs. M11, M12 vs. M13, M3 vs. M14, M15 vs. M16, 
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M17 vs. M18, M19 vs. M20, M21 vs. M22, M23 vs M24, M6 vs. M25. Different 
combinations of the single models are explored with gradual exclusion of models with inferior 
performance, such as LOG, SVMr and NN, to illustrate the effects of the number and quality 
of single models on the overall ensemble performance.   
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For the selection of the second-stage classifier, 9 different classifiers including K 
nearest neighbors [165], LOG, linear support vector machine [170], SVMp, SVMr, decision 
tree, random forest [171], AdaBoosted Tree [172], and Gaussian Naive Bayes [173], are 
explored, with hyper-parameters in each classifier tuned using the validation set. For each 
ensemble model, the classifier which achieved the best performance (averaged over 5 folds) 
in the validation set is selected as the second-stage classifier. The training and evaluation of 
the in the validation set is selected as the second-stage classifier. The training and evaluation 
of the classifier ensembles are implemented using Scikit-learn python package [174]. 
5.3.4 Evaluation 
To investigate the benefits of employing 3D CNN compared to 2D CNN, six 
additional 2D architectures, CNN4 – CNN9, as described in Table 5.1, were also evaluated. 
CNN9 is the comparable 2D network architecture of CNN1. CNN5 and CNN7 are simplified 
version of VGG network [135], which is one of the classic architectures used for the task of 
natural image classification. These three 2D networks map each 3D volumetric image into a 
3-channel 2D image by assigning 3 orthogonal views (axial, coronal and sagittal views 
centered at the nodule) to different input channels following the approach used in [139, 142, 
143]. CNN4, CNN6, and CNN8 replicate the model presented by Shen et al in [146], which 
utilize 3D input volumes and consider the 3rd dimension (z-axis) as the input channels. The 
same dataset (including the same image pre-processing, data augmentation and cross 
validation split) and the training strategy as described in the previous sections were used for 
the 2D model. The hyper-parameters, including the initial learning rate η0 and weight decay C 
parameter, were re-tuned for the 2D model based on the performance tested in the validation 
set. 
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The receiver operating characteristic (ROC) curve averaged over 5 cross-validation 
folds for each classifier is plotted and the respective area under the curve (AUC) and standard 
deviation (σ) is reported. As a measure of the difference between a pair of ROC curves, the 
statistical significance p-value (with significance level of 0.05) of the difference is computed 
based on the DeLong test [175]. The p-values for 5 cross-validation folds are combined using 
Fisher's method [176, 177]. The statistical tests on ROC curves are implemented using pROC 
R package [178].  
5.4 Results 
The performance comparison for all 9 presented CNN models, including 3 3D CNNs 
and 6 2D CNNs are summarized in Table 5.1. The detailed performance comparison of the 
best two 3D CNN models, CNN1 and CNN2 are summarized in Table 5.4. CNN1 
outperforms all of the other CNNs, thus it is used in the construction of ensemble models 
listed in Table 5.3. The performance for 7 single models and 18 ensemble models are 
summarized in Table 5.3. The columns marked by ⧾ indicate the classifiers included in the 
respective model on each row. The performance for each model is summarized in 6 rightmost 
columns, including overall AUC ± σ, AUC ± σ for each size bin, the p-values for the ROC 
difference compared to M3 (SVMp) and the p-values for the ROC difference compared to M6 
(2-bin). M3 and M6 are selected as reference because they are the best traditional size-
universal single model and the best traditional size-binned model respectively.  
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Table 5.4. The summary of performance of best two 3D CNN models, CNN1 and CNN2. The 
overall AUC and AUC for each size bin are averaged over 5 folds with corresponding 
standard deviation (σ) reported below. 
 
CNN models AUC for B6 ± σ AUC for B8 ± σ AUC for B12 ± σ Overall AUC ± σ 
CNN1 
(CNN-16-2conv) 
0.734 ± 0.051 0.804 ± 0.089 0.682 ± 0.119 0.732 ± 0.052 
CNN2 
(CNN-32-3conv) 
0.649 ± 0.058 0.738 ± 0.108 0.761 ± 0.082 0.698 ± 0.047 
 
 The comparison of the ROC curves of 7 single models (M1- M7) is shown in Figure 
5.5. Size-universal models (M1-M5) are plotted in solid line and size-binned models (M6 – 
M7) are plotted in dashed line. The comparison of ROC curves of 4 size-universal ensemble 
models (M8, M9, M12 and M13) is shown in Figure 5.6. Two single models M3 SVMp and 
M5 CNN are also shown for reference, since they are the best traditional size-universal single 
model and the best size-universal single model respectively. Models (M5, M9 and M13) that 
include CNN are plotted in solid lines and the models (M3, M8 and M12) that are built only 
with traditional models are plotted in dashed lines. The comparison of ROC curves of 3 size-
binned ensemble models (M15, M16 and M25) is shown in Figure 5.7. Two single models 
M6 2-Bin and M5 CNN (size-universal) are also shown for reference, since they the best 
traditional single model and the best size-universal model respectively. Models (M5, M16 and 
M25) that include CNN are plotted in solid lines and the models (M6 and M15) that are built 
only with traditional models are plotted in dashed lines. For the clarity of the figures, not all 
ensemble models in Table 5.3 are included in the plots.  
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Figure 5.5. The comparison of ROC of single models M1 to M7. The size-universal models 
(M1 to M5) are plotted in solid lines, and the size-binned models are plotted in dashed lines 
(M6 to M7). 
 
 
Figure 5.6. The comparison of ROC of size-universal ensemble models M8, M9, M12, and 
M13. Two single models M3 SVMp and M5 CNN are also shown for reference. Models that 
include CNN are plotted in solid lines, and the models that are built only with traditional 
models are plotted in dashed lines. 
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Figure 5.7. The comparison of ROC of size-binned ensemble models M15, M16, and M25. 
Two single models M6 2-bin and M5 CNN (size-universal) are also shown for reference. 
Models that include CNN are plotted in solid lines, and the models that are built only with 
traditional models are plotted in dashed lines. 
 
5.5 Discussion 
The task of 3D nodule analysis in lung cancer screening differs from the traditional 
tasks in 2D imaging in that there is a very wide range of nodule sizes, resulting in the number 
of pixels on target for a nodule varying by a factor of 57 in our dataset. The difference in 
resolution is illustrated by Figure 5.8 (g, n). With the CNN1 (16x16x16) model, the largest 
27.6% of the nodules were slightly under-sampled with most of these nodules in the B12 
group, while there was no under-sampling for the CNN2 (32x32x32) model. This may 
account for the difference in performance between the two models as shown in Table 5.4. The 
CNN1 model had better performance for the smaller nodules in B6 and B8 group, while the 
CNN2 model exhibited better performance for the larger and more detailed nodules in B12 
group. A better classification model can be constructed without any re-training by simply 
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using CNN1 for nodules in B6 and B8 and using CNN2 for nodules in B12, and achieves 
overall AUC ± σ as 0.761 ± 0.084, although the ROC difference is not statistically significant 
with respect to CNN1. 
The size-universal single classification model of 3D CNN (M5) has been shown to 
achieve better AUC compared to the size-universal single models (M1- M4) constructed using 
handcrafted features and traditional machine learning approaches as shown in Figure 5.5 and 
Table 5.3, although the ROC difference between the 3D CNN model and the best traditional 
model M3 is not statistically significant (p-value 0.256). Since the exact same 5-fold training 
and testing partition and evaluation scheme were used, the direct performance comparison 
demonstrates the strength of the 3D CNN approach with the benefits of eliminating manual 
feature design and selection, which relies on task-specific expert knowledge and can be rather 
time consuming. Moreover, due to the much smaller scale of available training examples 
compared to computer vision applications in natural images [131, 134, 135, 136], it is 
reasonable to hypothesize that better performance can be obtained by the 3D CNN model, if 
more training examples are available and thus deeper network architectures can be utilized, 
based on the relation between the performance and dataset size observed in other studies [146, 
179]. 
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Figure 5.8. (a-e) Five axial CT slices sampled from the input 3D volume of a nodule (nodule 
1) with diameter of 5.1 mm. (f) the segmentation of nodule 1 shown in 3D axial view. (h - l) 
Five axial CT slices sampled from the input 3D volume of a nodule (nodule 2) with diameter 
of 12.09 mm. (m) the segmentation of nodule 2 shown in 3D axial view. (g) and (n) are axial 
slices cropped from original CT before rescaling, as the counterpart of (c) and (j) respectively. 
Since the nodules are first cropped based on nodule size and then scaled to the same image 
size, the image appearance of the nodule and nearby structures (such as vessels) can be rather 
different.   
 
The size-binned single models (M6 and M7) outperform all the size-universal single 
models (M1 – M5) as shown in Figure 5.5 and Table 5.3, although the ROC difference 
between the best size-binned model M6 and the best size-universal model 3D CNN M5 is not 
statistically significant (p-value 0.444). It suggests that given more training examples, a size-
binned 3D CNN model may potentially achieve better performance than its size-universal 
counterpart, because of the advantage of considering the nodules of different size range 
separately. Additionally, in the presented size-universal 3D CNN model, to ensure a uniform 
target object scale that is usually considered as helpful for the training of CNNs, nodules of 
different sizes are scaled to image volumes of the same size in pixels. This results in very 
different image representations of nodules and nearby structures, such as more blurring effect 
and larger scale of the attached vessels for small nodules, as illustrated in Figure 5.8, and thus 
has a potential negative effect on the final classification performance. Unfortunately, due to 
the limited size of current dataset, a size-binned 3D CNN cannot be trained to converge, as it 
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means only 44.79% of the training set can be used to train a 3D CNN for size bin B6, 28.22% 
training set for bin size B8, and 26.99% training set for bin size B12. Finally, for all models 
shown in Table 5.3, the best overall AUC is 0.735 for B6, 0.823 for B8 and 0.830 for B12, 
which is consistent with classification of small nodules being more challenging [126, 128] 
due to the larger number of on target pixels for larger nodule. 
 
Figure 5.9. Examples of malignant nodules N1 – N4 (a – h) shown on the first row and 
benign nodules N5 – N8 (i – p) shown on the second row. For each nodule, the central axial 
slice from CT scan is shown on the left and the segmentation of each nodule is shown in 3D 
axial view on the right.  
 
The incorporation of 3D CNN model into the ensembles of other traditional models 
always leads to performance enhancement compared to the ensemble counterparts without the 
3D CNN as shown in Table 5.3, Figure 5.6 and Figure 5.7 (solid lines vs. dashed lines). The 
models with best performance in each of the three categories shown in Table 5.3, including 
M5 for size-universal single model, M13 for size-universal ensemble model and M25 for size- 
binned ensemble model, all include 3D CNN in its composition, whereas the simple 
combination of traditional models, such as M8, M10, M12, M15, M17, M19, M21 and M23, 
can only lead to negligible performance improvement compared to the best single model, with 
no statistical significance, as indicated in Table 5.3. The ROC differences between the best 
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performance ensemble models and the respective best performance traditional single model, 
i.e., M13 vs. M3, and M25 vs. M6, are statistically significant (p-values < 0.01).  
The results on the ensemble models demonstrate that the diversity among the 
individual models in the composition is the key to the success of the ensembles, which is 
consistent with the discussion by Kittler et al. [163] and Kuncheva et al. [164]. As illustrated 
in the examples given in Figure 5.9 and Figure 5.10, misclassifications by different single 
classifiers (M1- M7) often do not overlap; consequently, different single classifiers usually 
exhibit complementary advantages in recognizing different image patterns, leading to an 
optimized classifier ensemble. Since all the traditional models explored in this paper are built 
upon the same set of handcrafted image features and trained with the same training data, the 
diversity among them are limited. On the contrary, the 3D CNN model takes the raw image 
volumes as inputs and learns the features automatically by the network itself, which often 
provides complementary information about the image patterns to be classified compared to 
the traditional models [139, 143], and thus can potentially be harnessed to improve the overall 
ensemble performance.  
Excluding single models with inferior performance from the ensemble models can also 
be beneficial to the ensemble performance as can been seen in the comparison of M13 vs. M9, 
and M25 vs. M16 in Table 5.3. On the other hand, excluding more single classifiers with 
inferior performance may be detrimental to the ensemble performance due to the decreased 
diversity as can been seen in the comparison of M14 vs. M13 in Table 3. Therefore, the 
number of single models to be included needs to be optimized in the construction of ensemble 
models.  
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Figure 5.10. The model response output by 7 single models (M1 – M7) and the best ensemble 
model (M25) for nodules N1 – N8 as defined in Figure 5.9. Malignant nodules N1 – N4 (a – 
d) are shown in the left column and benign nodules N5 – N8 (e – h) are shown in the right 
column. For the purpose of direct comparison, the classifier response output by each model 
has been normalized to zero mean and unit standard deviation. A larger value of response 
indicates a higher probability for malignancy predicted by the model. 
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This paper is the first study to employ a 3D CNN trained from scratch to address 
pulmonary nodule classification from low-dose chest CT. Due to the consideration of the full 
3D image volume, it has the potential for better performance [148, 150, 151] compared to 
other work based on 2D CNN [143, 153]. In addition, unlike using a pre-trained CNN in the 
study [143] by Buty et al., training a CNN from scratch eliminates the constraint on using the 
same network architecture as the pre-trained CNN, which may be suboptimal for the specific 
task of interest [140, 141]. However, in the situation where the computation resource is 
limited and the training data is insufficient to train a deep neural network, which is often true 
for automated applications in medical imaging [140], the use of 2D CNN becomes attractive, 
because it avoids the need of training from scratch and allows the utilization of off-the-shelf 
deep features and fine-tuning from pre-trained networks that were trained with large-scale 
annotated natural image datasets [132, 140].   
To quantify the benefit of using a 3D CNN architecture for pulmonary nodule 
classification, six 2D CNN models, CNN4 – CNN9, were also evaluated as shown in Table 
5.1. 3D model CNN1 outperforms all the 2D CNN models, suggesting the strength of 
considering all 3D information and employing of 3D architectures. 
The malignancy status of nodules was established in this paper by either biopsy or 
histology of resected tissue, which should be considered as a much more reliable truth 
reference compared to the subjective malignancy ratings of radiologists. The nodules exhibit a 
significant intra-class variation in image appearance on CT scans, i.e., a wide variation in 
among the same class (benign or malignant), as demonstrated by the examples listed on the 
same row in Figure 5.9; whereas the inter-class variations can be small, i.e., the appearance of 
the benign and malignant nodules can be rather similar, which makes the visual 
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discrimination between benign and malignant nodules challenging, as demonstrated by the 
examples listed in the same column in Figure 5.9. As shown in the observer study in LUNGx 
Challenge [122], the inter-observer variations among experienced thoracic radiologists in the 
task of malignancy rating even on diagnostic chest CT are significant, with AUC ranging 
from 0.70 to 0.85. As a result, the presented study cannot be directly compared to the studies 
using subjective malignancy ratings as truth reference [125, 143, 145, 146].     
In the future work, there are two possible extensions to consider. First, different 
ensemble classifiers can be trained for nodules of different size ranges to take advantage of 
the fact that the performance for some single classifier is superior for one size bin but inferior 
for another size bin. Second, the complementary information learned by conventional 
classifiers can be incorporated into the CNN by feeding predictions of conventional models or 
handcrafted features as input to the FC layers, and then trained from end-to-end to replace the 
use of ensemble classifiers. 
5.6 Conclusion 
This study presents a 3D CNN trained from scratch for the challenging task of 
classifying pulmonary nodule malignancy from low-dose chest CT obtained from the annual 
screening of lung cancer. The dataset consisting of 326 nodules is constructed with balanced 
size and class distribution with the malignancy status pathologically confirmed. The 
experiments were designed to replicate those in the study [126] by Reeves et al. by using the 
exact same 5-fold training and testing partition, truth definition and evaluation scheme for the 
direct performance comparison of the 3D CNN and conventional approaches. The results 
demonstrate three primary advantages of applying 3D CNN to pulmonary nodule 
classification. First, both the 3D CNN single model (AUC of 0.732) and the ensemble models 
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with 3D CNN (AUC of 0.780) outperform the respective counterparts constructed using only 
traditional machine learning models (AUC of 0.708 for the best single traditional model, and 
AUC of 0.748 for the best ensemble model constructed without CNN). Second, 3D CNN 
models eliminate the procedure of manual feature design and selection that are required by the 
traditional machine learning models and rely heavily on the domain-specific expert 
knowledge. Third, complementary information of nodules can be learned by the 3D CNN and 
the conventional models, which together are combined to construct an ensemble model with 
statistically significant performance improvement (p-value < 0.05) compared to any single 
traditional model in its composition. Although the current best performance model with AUC 
of 0.780 is insufficient for direct diagnosis in the clinical practice, the automated prediction 
outcome may be useful in improving the lung cancer screening follow-up protocol which 
currently depends mainly upon the nodule size. 
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CHAPTER 6 
CONCLUSION 
A fully automated framework has been presented in this dissertation for the 
measurement and evaluation of quantitative image biomarkers from LDCT scans acquired 
during the annual lung cancer screening. Quantitative image biomarker measurements from 
the regions of breasts, bones, airway and lungs have been accomplished respectively and 
demonstrated to be able to potentially assist and even improve the comprehensive 
interpretation of medical images.  
 An anatomy directed approach is applied to the analysis of breast region and to the 
measurements of breast density for women and of gynecomastia quantification for men. The 
automated density assessment has been demonstrated to be consistent with the subjective 
reading of an experienced radiologist in 97 of 100 scans. Therefore, breast density assessment 
from LDCT can potentially serve as a valuable resource providing useful information with 
respect to breast cancer risk evaluation for many women who have undergone LDCT but not 
recent mammograms. The automated gynecomastia measurements have been demonstrated to 
achieve promising performance for the gynecomastia diagnosis with the AUC of 0.86 for the 
ROC curve and have statistically significant Spearman correlation r=0.70 (p < 0.001) with the 
reference categorical grades established by an experienced radiologist. The encouraging 
results demonstrate the feasibility of fully automated gynecomastia quantification from 
LDCT, which may assist the early detection as well as the treatment of both gynecomastia and 
the underlying medical problems, if any, that cause gynecomastia. 
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 Fully automated BMD assessment based on CT image attenuation (HU) is achieved by 
building upon the model-based segmentation and anatomical labeling of individual vertebral 
body. Statistically significant (p-value < 0.001) strong correlation can be obtained between 
BMDCT and the reference BMDDXA at all vertebral levels (T1 – L2). The highest Pearson 
correlation of 0.857 is achieved between BMDDXA and the average BMDCT of T9-T11. The 
encouraging results demonstrate the feasibility of fully automated quantitative BMD 
assessment and the potential of opportunistic osteoporosis screening with concurrent lung 
cancer screening using LDCT. 
A fully automated knowledge-based approach is applied to the segmentation and 
anatomical labeling of each airway bronchus, which enables the measurements of precise and 
reproducible airway dimension derived biomarkers, the lumen diameter and wall thickness, 
for each labeled bronchus. The airway biomarker measurements are evaluated with a 
longitudinal dataset of 504 LDCT cases, which demonstrates good reproducibility and 
therefore provides valuable information to aid the diagnosis and treatment of COPD. 
For the classification of pulmonary nodule malignancy, a 3D CNN is trained from 
scratch and demonstrates various advantages over both the traditional machine learning 
approaches (with the use of hand-crafted 3D image features) and the 2D CNN models. 
Classifier ensembles of the combinations of the 3D CNN and traditional machine learning 
models achieve the best performance by taking advantage of the complementary 
characteristics of the traditional models and the CNN models. Although the current best 
performance model with AUC of 0.780 is insufficient for direct diagnosis in the clinical 
practice, the output prediction of the automated system may be useful in assisting 
radiologist’s decision making on the lung cancer screening follow-up plan. 
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In conclusion, with the recent large-scale implementation of annual lung cancer 
screening in the US using LDCT, great potential emerges for the concurrent extraction of 
quantitative image biomarkers from different regions in the chest, including lungs, heart, 
vertebrae, breasts, etc., which are covered in LDCT scans acquired during annual lung cancer 
screening. This dissertation has demonstrated the feasibility of fully automated measurement 
and evaluation of a rich set of quantitative image biomarkers, and the opportunity to 
significantly enhance the impact of LDCT acquired in the annual lung cancer screening by 
offering a comprehensive health assessment to each screening participant with no additional 
imaging or radiation exposure.    
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